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 ABSTRACT 
 
 Methylmercury (MeHg) is a ubiquitous environmental toxin. Exposure to MeHg 
in humans occurs primarily through the consumption of contaminated seafood. MeHg has 
been shown to act most strongly during neural development. Epidemiological data on the 
effect MeHg exposure through seafood has on children and fetuses is conflicted, with 
large cohort studies showing both presence and absence of MeHg-induced deficits in 
achieving developmental milestones. Because of this uncertainty in the literature it is 
important that we come to understand the mechanisms of MeHg toxicity so that we might 
advise the public more accurately on the risks of MeHg exposure. 
 Research into the mechanisms of MeHg toxicity has found a number of cellular 
and molecular effects including disruptions of microtubule formation, Ca2+ homeostasis, 
and glutamate signaling. However, none of these effects of MeHg fully explains its 
neurodevelopmental specificity. Previous work in Drosophila neural-derived cell lines 
has shown that MeHg causes upregulation of the canonical Notch response gene 
E(spl)mδ. The Notch pathway is crucial to neural development and perturbation of a 
Notch target may explain the developmental specificity of MeHg. In this dissertation I 
describe experiments I performed to test the hypothesis that the observed upregulation of 
E(spl)mδ plays an important role in MeHg toxicity in Drosophila. 
 I first describe experimental evidence that E(spl)mδ is upregulated by MeHg 
treatment in vivo in Drosophila embryos in addition to cells, as has previously been 
shown. By contrasting the effects of the toxic inorganic mercurial HgCl2 with MeHg I 
show that the E(spl)mδ expression response to MeHg is not simply a stress response and 
is a likely specific activity of MeHg. I also show that the effect of MeHg on E(spl)mδ 
expression is not simply due to a developmental delay induced by the toxin. 
 I also identify two neural phenotypes of MeHg toxicity in Drosophila embryos, in 
the outgrowth of the intersegmental and segmental motor nerves. Genetic manipulation 
causing overactivity of the Notch pathway in neurons can mimic these phenotypes. 
However, induced expression of E(spl)mδ in neurons does not cause a failure of motor 
nerve outgrowth. Upon further examination I demonstrate that endogenous expression of 
E(spl)mδ occurs in the muscle. Induced E(spl)mδ expression in the muscle causes a 
segmental nerve phenotype similar to MeHg treatment, indicating a role for E(spl)mδ in 
MeHg toxicity in this system. MeHg treatment and E(spl)mδ overexpression in the 
muscle causes a failure of normal muscle development. Yet, this gross developmental 
abnormality only partially explains the observed motor nerve phenotype. E(spl)mδ is 
unique among the E(spl) genes in its ability to cause these muscle and motor nerve 
phenotypes as shown by contrasting genetic manipulation of the closely related E(spl)mγ. 
 Overall my findings support the hypothesis that MeHg toxicity in Drosophila is 
mediated in part by E(spl)mδ. They also suggest that E(spl)mδ plays an important role in 
the formation of the muscle during embryonic development, contributing to the literature 
describing disparate functions for E(spl) genes despite structural similarities. Finally, my 
findings suggest that MeHg may be able to impact neural development through toxicity 
in supporting tissues rather than neurons themselves. This final finding has implications 
for the study of MeHg toxicity in humans, and is supported by previous findings that 
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CHAPTER 1: LITERATURE REVIEW 
 
1.1: Introduction 
Methylmercury (MeHg) is a ubiquitous environmental contaminant with well 
known neurotoxic effects in humans. Acute and chronic high dose exposures due to 
industrial or agricultural accidents have revealed that MeHg exposure in adults causes a 
diffuse central neuropathy leading to mental, sensory, and motor deficits. The developing 
central nervous system has proven even more sensitive to MeHg toxicity; children 
exposed in utero to MeHg in doses that showed subtle signs in the mother have been born 
with profound neurological deficits including severe mental retardation, seizures, 
cerebellar ataxia, and sensory deficit. It is hypothesized that even low dose exposure to 
MeHg in utero due to maternal fish consumption can cause subtle developmental deficits, 
due to the increased sensitivity of the fetal system to MeHg. Because of this the cellular 
and molecular mechanisms of MeHg toxicity during development are the subjects of 
intense scrutiny. It has been shown in vitro in cell lines derived from the model 
organisms Drosophila melanogaster and Mus musculus that the traditional Notch targets 
in the Enhancer of Split [E(spl)] complex are upregulated after treatment with MeHg 
(Tamm et al., 2008). Since the Notch pathway is crucial to cell-fate determination during 
development this perturbation of the E(spl) complex may be a core underlying 
mechanism in the developmental neurotoxicity of MeHg. This work investigates the 
effects of MeHg on neural development and interactions with the Notch pathway in vivo 








Pathology and epidemiology of methylmercury poisoning 
 Much of the information available on the pathology of MeHg poisoning stems 
from two incidents of accidental mass poisoning of a population. During the 1940-1960’s 
the Chisso Corporation produced MeHg as a byproduct of acetaldehyde synethesis 
(Ekino et al., 2007). They released the MeHg in chemical waste dumped into rivers 
flowing into Minamata Bay, a source of dietary fish and shellfish for the inhabitants of 
the Minamata region of Japan (Ekino et al., 2007). Ingestion of the MeHg contaminated 
seafood caused acute toxicity in the population (Ekino et al., 2007). Continued exposure 
to MeHg released into Minamata Bay and the Shiranui Sea as recently as 1968 has 
caused chronic toxicity (Ekino et al., 2007). Exposure in utero to concentrations of MeHg 
causing only mild toxicity in the mothers has had profound effects on the child, 
indicating that the developing nervous system is particularly vulnerable (Ekino et al., 
2007). In 1956 MeHg poisoning due to contamination of the Minamata Bay was 
officially recognized and the clinical manifestation of MeHg poisoning was named 
Minamata disease (MD) (Ekino et al., 2007). 
 The second mass contamination of a population with MeHg occurred in the 
1970’s in Iraq. Seed grain given as agricultural aid was treated with MeHg as an 
antifungal (Myers and Davidson, 2000). Consumption of this grain caused acute 
poisoning in the population (Myers and Davidson, 2000). Because the source of the 
poisoning was quickly identified and consumption ceased, exposure was in a large bolus 
dose, opposed to the Minamata event, in which exposure was to chronic, relatively low 





allowed immediate study of the results, and reinforced the data indicating MeHg acted 
most potently on the developing nervous system (Myers and Davidson, 2000). 
 MD is often classified into three subgroups: acute, chronic, and fetal. Acute MD 
is found in adults who are exposed to large doses of MeHg. Postmortem analysis of 
affected individuals indicates diffuse cortical and cerebellar neuropathy (Taber and 
Hurley, 2008). This results in sensory, motor, and psychiatric deficits. The visual field 
shows bilateral concentric constriction (Ekino et al., 2007). There is a deficit in speech 
discrimination (Ekino et al., 2007). Olfaction and gustation show subjective changes 
(Ekino et al., 2007). There is loss of sensitivity and two point discrimination in the distal 
extremities (Ekino et al., 2007; Taber and Hurley, 2008). Cerebellar ataxia is common 
(Ekino et al., 2007; Taber and Hurley, 2008). Changes in personality including lack of 
volition and apathy are nearly ubiquitous (Ekino et al., 2007; Taber and Hurley, 2008). 
 Individuals suffering from chronic MD show similar deficits. A stocking and 
glove pattern loss of sensation in the distal extremities was thought to indicate a 
peripheral neuropathy. Further research, however, has shown that affected individuals 
show no reduction in tendon reflexes and have unaltered peripheral conduction velocities, 
indicating a central neuropathy (Ekino et al., 2007). Cerebellar ataxia has been shown 
during early exposure to MeHg, but improves over time; chronic MD patients still show 
deficits in movement and posture, however, due to sensory deficits resulting in sensory 
ataxia (Ekino et al., 2007). Visual and auditory deficits have also been reported in chronic 
MD patients (Ekino et al., 2007). 
 The most severe form of MD affects individuals exposed during development in 





difficulty with most coordinated or involuntary motor tasks including chewing, 
swallowing, speaking, and walking (Ekino et al., 2007; Taber and Hurley, 2008). Severe 
cases result in akinetic mutism (Ekino et al., 2007; Taber and Hurley, 2008). 
 Because of the sensitivity of the developing nervous system to MeHg there has 
been much concern about the effects of low doses of MeHg on children and fetuses. 
Mercury can be found in many large bodies of water due to contamination from natural 
and anthropogenic sources (Myers and Davidson, 2000; Clarkson et al., 2003). Aquatic 
bacteria can turn elemental mercury into MeHg, which concentrates in large predatory 
fish due to bioamplification. Fish and other seafood makes up a significant portion of the 
diet of many populations, and through it they are exposed to MeHg (Myers and 
Davidson, 2000; Clarkson et al., 2003). Several epidemiological studies have attempted 
to identify effects of subacute dietary MeHg in developing individuals. Two studies stand 
out because of their large sample sizes and methodological rigor: the Faroe Islands and 
Seychelles Islands studies (Myers and Davidson, 2000). 
 The Faroes population is exposed to MeHg primarily through the consumption of 
pilot whale blubber (Myers and Davidson, 2000; Castoldi et al., 2008a; Rice, 2008; Taber 
and Hurley, 2008). In the study of this population MeHg was associated positively with 
neurodevelopmental milestones in the first year after birth. This can be explained by an 
association between breastfeeding and MeHg exposure during that timeframe (Grandjean 
et al., 1995; Myers and Davidson, 2000; Castoldi et al., 2008a; Rice, 2008). At 7 years of 
age, though, increased MeHg exposure prenatally (as measured by cord blood 





learning, and attention (Grandjean et al., 1997; Myers and Davidson, 2000; Castoldi et 
al., 2008a; Rice, 2008). 
 The Seychelles Islands population is exposed to MeHg via deep sea and reef fish 
(Myers and Davidson, 2000; Castoldi et al., 2008a; Rice, 2008; Taber and Hurley, 2008; 
Myers et al., 2009). In the study of this population no negative effects were observed 
from increased exposure to MeHg, either pre or postnatal. In fact, there were beneficial 
effects shown to correlate with the amount of fish consumed (Davidson et al., 1995; 
Myers et al., 1995; Myers and Davidson, 2000; Castoldi et al., 2008a; Rice, 2008; Taber 
and Hurley, 2008; Myers et al., 2009). 
 The discordance found between the Faroe and Seychelles island studies has been 
the topic of much debate. Many factors might have contributed to their disparate results. 
One of the primary differences is the source of the MeHg. Pilot whale blubber is eaten 
infrequently on the Faroes, but has a higher concentration of MeHg than fish. It also 
contains other toxic contaminants such as polychlorinated biphenyls (Myers and 
Davidson, 2000; Castoldi et al., 2008a; Rice, 2008; Taber and Hurley, 2008). The fish 
eaten in the Seychelles contains omega-3 fatty acids and selenium, factors that may be 
beneficial to neurodevelopment, and as such oppose the effects of MeHg (Myers and 
Davidson, 2000; Castoldi et al., 2008a; Rice, 2008; Taber and Hurley, 2008). There are 
also some methodological differences, such as a failure to correct for socioeconomic 
effects in the Faroes study (Rice, 2008). Because of the opposing findings of the studies it 
is still uncertain what risks the consumption of seafood might pose for fetuses and 
children. Future studies may be aided by the use of neurophysiological metrics rather 





show alterations in heart rate variability (HRV) indicating parasympathetic hypoactivity 
and changes in the latency of brainstem auditory evoked potentials (BAEP) correlating 
with MeHg exposure (Murata et al., 2007). These physiological tests will allow for data 
that is completely objective and should be comparable across cultures (Murata et al., 
2007). 
 Animal models also allow the study of MeHg toxicity without the confounding 
effect of diet or culture. Studies on non-human primates have shown similar effects to 
those in humans, excepting only a relative sparing of the cerebellum in monkeys and 
ambiguous results on cognitive development (Castoldi et al., 2008b). Rodent models also 
show similar effects to humans, but must be used with care as the timeframe of 
neurodevelopment is quite different than humans, with the third trimester in humans 
roughly corresponding to the first 10 postnatal days in rats (Castoldi et al., 2008b). 
Despite differences these animal models will continue to be useful for elucidating the 
effects of MeHg toxicity, since every variable can be more closely controlled and 
measured. 
 
Methylmercury Biochemistry and Transport 
 Human exposure to MeHg occurs primarily through contaminated fish and other 
seafood. In fish MeHg is most commonly found bound to the amino acid cysteine as 
MeHg-cysteinate (Harris et al., 2003). This compound consists of the MeHg bound to the 
thiol group of cysteine. MeHg shows a high affinity for thiols, and can rapidly exchange 
between thiols in solution, allowing it to jump from protein to protein, binding to their 





is known to bind to DNA the affinity of MeHg for DNA is much lower than that for 
thiols and no genotoxic effects of MeHg have been observed (Maki and Ott, 1981; Li et 
al., 2006; Carmona et al., 2008). It has been shown in vitro that MeHg-L-cysteinate 
crosses the plasma membranes of cells in a temperature sensitive process, indicating a 
protein transporter (Heggland et al., 2009). MeHg-chloride (MeHgCl), however, crosses 
the plasma membrane in a temperature insensitive process, implying passive diffusion 
(Heggland et al., 2009). In MeHgCl the mercury-chloride bond is very strong and does 
not spontaneously dissociate in aqueous solution, however the strong affinity of MeHg 
for thiol groups allows rapid production of MeHg-cysteinate from MeHgCl upon addition 
of cysteine (Harris et al., 2003; Heggland et al., 2009; Asaduzzaman et al., 2010).  
 Once consumed MeHg is taken up in the gut by L-type large amino acid 
transporters (Clarkson and Magos, 2006; Hoffmeyer et al., 2006; Clarkson et al., 2007; 
Heggland et al., 2009). MeHg then enters the blood where it accumulates in red blood 
cells and binds to cysteine residues on hemoglobin and glutathione (Doi and Tagawa, 
1983). The MeHg then distributes to tissues throughout the body, leaving the red blood 
cells with glutathione and entering other tissues after binding free cysteine (Doi and 
Tagawa, 1983). In this manner it can cross the placental and blood-brain barrier 
(Clarkson and Magos, 2006; Clarkson et al., 2007). Some MeHg is excreted with 
glutathione in the bile, but breakdown of the glutathione releases MeHg-cysteine, which 
can be reabsorbed, forming an enterohepatic cycle (Clarkson and Magos, 2006; Clarkson 
et al., 2007). A small amount of MeHg in the gut is converted to inorganic mercury by 






 Many early studies investigated the distribution of MeHg in the various cell 
compartments of animals fed or injected with radiolabeled MeHg. Subcellular 
fractionation of tissues including brain, liver, and kidney showed MeHg accumulation in 
the lysosome/peroxisome, microsome, and mitochondrial fractions (Norseth and 
Brendeford, 1971; Syversen, 1974; Mehra and Choi, 1981). Each of the studies also saw 
MeHg accumulation in the nuclear fraction, though contamination of this fraction by 
other organelles cast doubt on whether the nuclei themselves contain MeHg (Norseth and 
Brendeford, 1971; Syversen, 1974; Mehra and Choi, 1981). An investigation using 
microautoradiographic imaging to determine MeHg distribution in the liver found 
evidence for MeHg in nuclei, reinforcing the finding from cell fractionation (Sakai, 
1975). It is thus possible that MeHg has effects in any cell compartment; specifically, its 
effects on E(spl) gene expression may be due to direct interaction with nuclear proteins. 
 
Cellular and molecular effects of methylmercury 
 The mechanisms of MeHg toxicity have not yet been fully elucidated. There has 
been a great effort to characterize the cellular and molecular effects of MeHg in order to 
begin understanding these mechanisms of toxicity. An important first step has been 
understanding the deposition and elimination of MeHg in the body. 
 MeHg is readily absorbed in the gastrointestinal tracts with about 95% of the 
MeHg consumed being absorbed (Clarkson and Magos, 2006). Within three days most of 
the MeHg distributes out of the blood into other tissues (Clarkson and Magos, 2006). 
Brain tissue shows five times more MeHg than the blood and scalp hair shows MeHg at 





Recent research has revealed MeHg causes disruption of microtubule formation. 
By binding to tubulin MeHg has been shown to inhibit polymerization and depolymerize 
assembled tubules (Castoldi et al., 2001; do Nascimento et al., 2008). This has been 
observed in many cell lines, including human fibroblasts, neuroblastoma, and glioma 
cells (Castoldi et al., 2001; do Nascimento et al., 2008). Microtubule formation is 
critically important to many processes, not the least of which is neural development. This 
disruption of microtubules is consistent with the effects of MeHg on the brains of infants 
exposed in utero in Iraq; they showed a reduction of brain size and disordering of brain 
arrangement which could have been caused by lack of microtubule formation (Castoldi et 
al., 2001; do Nascimento et al., 2008). 
MeHg has also been shown to disrupt calcium homeostasis. Calcium ions (Ca2+) 
have been shown to play a role in central nervous cell death. At low concentrations 
MeHg has been shown to cause increased intracellular Ca2+ concentrations in cerebellar 
cell culture (Castoldi et al., 2001; do Nascimento et al., 2008). Ca2+ channel blockers and 
the Ca2+ chelator BAPTA protected these cells from MeHg-induced cell death (Castoldi 
et al., 2001; do Nascimento et al., 2008). In vivo administration of voltage-dependant 
Ca2+ channel blockers protected rats from neurological disorders due to MeHg treatment 
(Castoldi et al., 2001; do Nascimento et al., 2008). 
Much work has focused on the effects of MeHg on the glutamatergic system and 
oxidative stress. MeHg has been shown to accumulate in astrocytes where it inhibits 
uptake and stimulates release of the excitatory neurotransmitter glutamate (Castoldi et al., 
2001; Aschner et al., 2007; do Nascimento et al., 2008). This increased concentration of 





activates its receptors, which cause an increase in Na+ influx, which leads to release of 
Ca2+ from intracellular stores (Castoldi et al., 2001; Aschner et al., 2007; do Nascimento 
et al., 2008). This in turn leads to the generation of reactive oxygen species (ROS), which 
accumulate and kill the neurons (Castoldi et al., 2001; Aschner et al., 2007; do 
Nascimento et al., 2008). The central role of glutamate accumulation in MeHg toxicity 
has been reinforced by experiments which show that cotreatment with N-methyl-D-
aspartate (NMDA) receptor antagonists can attenuate the toxic effects of MeHg in 
cerebral neuron culture (Castoldi et al., 2001; Aschner et al., 2007; do Nascimento et al., 
2008). These findings have led some researchers to postulate that the neurotoxic effects 
of MeHg are simply repercussions of its effects in astrocytes. Further work highlighting 
the importance of oxidative stress in MeHg toxicity involves the Nrf2/Keap1 complex. In 
this complex Keap1 binds to Nrf2, keeping it inactive in the cytosol; when Keap1 is 
modified by a perturbation of the oxidation state of the cell it releases Nrf2 which enters 
the nucleus and binds to antioxidant response elements (AREs) that regulate expression 
of traditional oxidative stress protectors, such as glutamate cysteine ligase (GCL), the rate 
limiting enzyme in the production of glutathione (Toyama et al., 2007). In human 
neuroblastoma SH-SY5Y cells treatment with MeHg has been shown to dissociate 
Nrf2/Keap1, allowing activation of AREs (Toyama et al., 2007). 
Other genetic and epigenetic effects have also been observed in response to MeHg 
exposure. Many metals, including cadmium, arsenic, nickel, and chromium have been 
shown to influence epigenetic changes. The common cause has been hypothesized to be 
DNA damage caused by oxidative stress (Baccarelli and Bollati, 2009). Perinatal MeHg 





factor (BDNF) regulation in the mouse hippocampus. Three major changes were 
observed in promoter IV of the BDNF gene: an increase in histone H3-K27 
trimethylation, an increase in DNA methylation, and a decrease in histone H3 acetylation. 
Each of these is consistent with the observed decrease in BDNF mRNA levels 
(Onishchenko et al., 2008). 
In Drosophila early work showed that MeHg was toxic at much lower doses than 
methoxyethyl mercuric compounds (Sorsa and Pfeifer, 1973). It was also found that 
MeHg altered the puffing pattern of the prepupal salivary chromosomes, a measure 
indicating changes in gene regulation due to MeHg exposure (Sorsa and Pfeifer, 1973). 
MeHg has shown no evidence of genotoxicity in Drosophila, though, likely due to 
lethality by other mechanisms at doses too low to cause genotoxic damage (Carmona et 
al., 2008). 
MeHg has also been shown to cause upregulation of genes in the Notch receptor 
pathway, specifically genes of the E(spl) complex, in Drosophila (Bland and Rand, 
2006). This effect has been shown to occur independent of the Notch receptor itself and 
its coactivator Suppressor of Hairless Su(H) (Rand et al., 2008). Because of the key role 
Notch and its targets play in the development of the nervous system, specifically in cell-
fate determination, this effect of MeHg on the E(spl) complex genes may prove crucial to 
the understanding of the neurodevelopmental toxicity of MeHg. To further investigate 








1.3: Notch pathway 
 The Notch cell-to-cell signaling pathway is involved in cell fate determination in 
many tissues.  It is crucial to neural development, and interference with it leads to serious 
failures in neural differentiation or migration, akin to those seen in fetal MD. 
 Notch receptor structure and function has been largely elucidated in the 
Drosophila model. Notch is classified as a neurogenic gene because mutations in it cause 
an increased number of neuroblasts to form in the neurectoderm, a region in the ventral 
part of the embryo of Drosophila melanogaster (Subiza et al., 1987; Campos-Ortega and 
Knust, 1990). Other neurogenic genes include Delta and the E(spl) complex, which was 
originally thought to be a single gene (Subiza et al., 1987; Campos-Ortega and Knust, 
1990). Early work established a link between Notch and E(spl), correctly identifying 
E(spl) as a downstream target of Notch (Subiza et al., 1987; Campos-Ortega and Knust, 
1990). It was soon recognized that E(spl) was not a single gene with a large neurogenic 
effect when mutated, but a complex of several genes which each produced a subtle 
phenotype (Preiss et al., 1988). 13 genes have been identified in the E(spl) complex: mδ, 
mγ, mβ, mα, m1, m2, m3, m4, m5, m6, m7, m8, and groucho (Fig. 1-1) (Wurmbach et al., 
1999) (Lai et al., 2000). Of these, seven (mδ, mγ, mβ, m3, m5, m7, m8) code for basic 
helix-loop-helix (bHLH) transcriptional repressors, four (mα, m2, m4, m6) code for 
Bearded family transcription factors, one (groucho) codes for a transcriptional 
corepressor, and one (m1) codes for a putative protease inhibitor (Wurmbach et al., 1999; 
Lai et al., 2000). 
 The Notch pathway is involved primarily in lateral inhibition during cell fate 





development of the Drosophila peripheral nervous system. In this system sensory organ 
precursors (SOPs) begin as groups of equipotent cells. The center cell expresses Delta, a 
ligand of Notch, which causes Notch activation in the surrounding cells, leading to a 
signal cascade that upregulates expression of E(spl) complex genes (Portin, 2002). Early 
evidence for the regulation of E(spl) by Notch was the distinct pattern of E(spl) 
expression in the epidermal cells surrounding neuroblasts during nervous system 
development in Drosophila, which corresponded to known patterns of Notch activation 
(Jennings et al., 1994). 
The Notch pathway has been shown to have a role in the development of many 
tissue types. The role of Notch in the developing nervous system is well studied. During 
development of the central nervous system in Drosophila embryos Notch causes lateral 
inhibition in a population of equipotent cells, allowing only some to differentiate into 
neuroblasts while the rest become epidermal cells (Portin, 2002). In the peripheral 
nervous system during embryo development Notch signaling plays a similar role, 
allowing some cells to become epidermal instead of nervous. Notch signaling is crucial to 
the proper formation of the sensory bristles during adult development (Portin, 2002). 
Notch is also involved in the development of the wing; in fact, the name Notch derives 
from the notched appearance of the wing in certain mutant strains. Notch signaling is 
involved in the development of wing veins; its ligand Delta is expressed in the region to 
become a vein, and Notch is expressed in the surrounding area, causing it to remain 
undifferentiated (Huppert et al., 1997). There is preliminary evidence that indicates Notch 
plays a role in the development of the Drosophila gut. The E(spl) gene mβ shows 





prepuparium (Maeder et al., 2009). Other E(spl) genes, such as mγ and mα have also 
been shown to be expressed in the developing midgut (Maeder et al., 2009). During the 
embryonic development of the muscles Notch has been shown to be involved in the 
differentiation of muscle progenitors and the maintenance of this cell population until 
muscle fusion, in which muscle founder cells orchestrate the formation of the final 
muscle pattern (Fuerstenberg and Giniger, 1998; Maqbool and Jagla, 2007; Vasyutina et 
al., 2007; Tixier et al., 2010). Notch has been shown to also have a role in oogenesis and 
development of the appendages and Malpigian tubules of Drosophila (Portin, 2002). 
Effects of Notch on neurite outgrowth have also been well-established, and will be 
addressed later. 
 It has been shown that various E(spl) genes perform certain roles better than 
others. mβ has been shown to be best at wing vein suppression and shows the most 
extensive expression in the gut (Ligoxygakis et al., 1999; Maeder et al., 2009), mδ 
performs best at lateral inhibition in the eye (Ligoxygakis et al., 1998), m7 and m8 have 
been shown to suppress bristle formation best (Ligoxygakis et al., 1999), and mγ has been 
shown to serve best at activating the gene cut during wing formation (Ligoxygakis et al., 
1999). Even the lesser studied Bearded family E(spl) genes have been shown to have 
specific effects; m6 overexpression causes increased bristle formation, but m2 
overexpression causes lack of bristles (Lai et al., 2000). The various E(spl) genes also 
express in different patterns. In the gut, for example, mβ dots the entire midgut while mγ 
is only expressed in two specific bands (Maeder et al., 2009). This differential expression 





restricted factors (Nellesen et al., 1999; Wech et al., 1999; Cooper et al., 2000; Maeder et 
al., 2007). The upstream enhancer regions of the E(spl) genes show patterns of Su(H) and 
proneural binding sites that are specific to each gene. Paired Su(H) sites and Su(H) sites 
paired with proneural sites are almost completely conserved among Drosophila species, 
indicating their importance (Maeder et al., 2007). Recent work has shown that the 
expression of m8 is heavily reliant on proneural proteins, but mγ shows little in vivo 
reliance on proneural proteins for its expression (Cooper et al., 2000). So it has been 
shown that the different E(spl) genes show distinct expression patterns and roles in Notch 
signaling; despite this there is some overlap of function, though, since no tissue expresses 
only one E(spl) gene and mutation of any one E(spl) shows little discernable phenotype 
(Wech et al., 1999). In fact, studies of single nucleotide polymorphisms (SNPs) in wild-
caught Drosophila melanogaster have shown that no significant association can be found 
between bristle number and E(spl) SNPs; one might expect there to be an association 
because of the important role of E(spl) in bristle development, but the fact that there isn’t 
reinforces the finding that E(spl) genes have some redundancy (Macdonald et al., 2005). 
 While much of the data on the Notch pathway has been generated in the 
Drosophila model its presence has also been verified in other systems. In the murine 
system four homologues of Notch have been identified, Notch1-4 (Jarriault et al., 1998). 
Homologues for the Notch ligands Delta and Serrate have also been found; Delta-like-1 
and Delta-like-3 are murine homologues of Delta and Jagged-2 is the murine homologue 
of Serrate (Jarriault et al., 1998). The Su(H) gene also has a murine homologue, named 
RBP-J (Jarriault et al., 1998). The murine homologues of the E(spl) genes are the HES 





Notch pathway has been identified in mice, and it works similarly to the Drosophila 
homologue: Delta-like-1 has been shown to activate Notch-1, which binds to RBP-J and 
enhances HES-1 expression (Jarriault et al., 1998). Because this pathway has proved to be 
highly conserved between Drosophila and mammals it has been identified as a ripe target 
for the study of toxicological effects; findings in Drosophila are likely to hold at least 
partially true in mammals (Rand, 2009). 
 
Notch signaling pathway overview 
 The molecular mechanisms of Notch signaling are well defined in Drosophila. 
The process progresses from activation of the Notch receptor to a signaling cascade that 
induces the ultimate effectors of the pathway, the E(spl) genes (Fig. 1-2). The E(spl) 
proteins function in lateral inhibition during tissue development, restricting most 
equipotent precursors from differentiating and allowing only the appropriate numbers of 
cells to assume a differentiated fate. 
Notch is a transmembrane receptor containing repeated elements of epidermal 
growth factor (EGF) motifs (Portin, 2002). Two Notch ligands have been identified in 
Drosophila, Delta and Serrate, which bind the EGF sites and cause Notch activation when 
expressed on the surface of neighboring cells (Portin, 2002). 
Once bound by a ligand the Notch extracellular domain is cleaved from the 
transmembrane/intracellular domains by ADAM (a disintegrin and metalloprotease) 
family proteases, such as Kuzbanian (Portin, 2002). After being cleaved from the 





the intracellular fragment into the cytosol, in a process mediated by a Presenilin/γ–
secretase protein complex (Portin, 2002). 
Once free the Notch intracellular domain localizes to the cell nucleus, where it 
binds Su(H) proteins (Bailey and Posakony, 1995). This Notch binding allows the 
disassociation of Su(H) from corepressors that cause it to act as a repressor of gene 
transcription (Bray and Furriols, 2001). In this manner Notch may act as a permissive 
activator of Su(H), allowing Su(H) to act on its own as a transcriptional enhancer; this is 
thought to be the case in many Notch activity-dependent processes that do not rely on the 
E(spl) complex, such as proneural enhancement (de Celis et al., 1996; Bray and Furriols, 
2001). Notch can also act as an instructive activator of Su(H), recruiting cofactors and 
facilitating the formation of a protein complex to activate Notch target genes; this is 
thought to be the case in Notch-dependant activation of E(spl) gene expression (Bray and 
Furriols, 2001). 
Once bHLH E(spl) proteins have been produced they facilitate lateral inhibition 
during cell differentiation (Jennings et al., 1999). By binding to DNA motifs that overlap 
with binding sites for proneural proteins the bHLH E(spl) proteins directly oppose the 
effects of the proneurals (Jennings et al., 1999). Since the proneurals are heavily involved 
in differentiation of cells the effect of the bHLH E(spl) proteins is to stop cells from 
differentiating due to proneural expression (Jennings et al., 1994). The roles of other 
E(spl) proteins, those in the Bearded family, groucho, and the putative protease inhibitor 
m1, are less well understood. 
Thus in the peripheral nervous system of Drosophila melanogaster during 





of equipotent groups of ectodermal lineage binds to Notch in the surrounding cells 
(Portin, 2002). Notch is cleaved twice, once by an ADAM protease and a second time by 
Presenilin, releasing the intracellular domain. The Notch intracellular domain enters the 
nucleus where it binds Su(H) and recruits additional cofactors to enhance expression of 
E(spl) genes (Bray and Furriols, 2001). The bHLH E(spl) proteins produced oppose the 
effects of proneural proteins, which prevents the surrounding cells where Notch was 
activated from becoming neuronal, while the center cell where Notch was not activated 
differentiates into a neural precursor (Jennings et al., 1999). 
 
Methylmercury and the Enhancer of Split locus 
 As early as 1973 it was noticed that MeHg has an effect on the genetics of 
Drosophila melanogaster; treatment with MeHg was observed to alter the puffing pattern 
of prepupal salivary chromosomes (Sorsa and Pfeifer, 1973). While this method certainly 
does not have the power of modern techniques it does indicate the ability of MeHg to 
affect the Drosophila genome. Recent studies have underscored the potential importance 
of the gene regulatory effects of MeHg on its toxicity. 
 It has been shown that treatment of neural-derived Drosophila cell lines and 
whole embryos with MeHg induces expression of genes in the E(spl) complex (Bland and 
Rand, 2006; Rand et al., 2008). This expression was initially attributed to an increase in 
Notch cleavage and thus presumed to increase signaling via the Notch intracellular 
domain (Bland and Rand, 2006). This was supported when knockdown of Notch 
expression using interfering RNA (RNAi) attenuated the response of the mγ gene to 





response to MeHg indicated an increase in gene expression in as little as three hours of 
MeHg treatment (Rand et al., 2008). Looking at RNAi knockdown of Notch and Su(H) at 
this time point revealed no effect of either on MeHg-induced mγ expression (Rand et al., 
2008). This conflicting data might indicate that Notch is involved in a secondary effect of 
MeHg and that it does not play a role until after the initial three hour time point (Rand et 
al., 2008). This is supported by the finding that the pattern of E(spl) gene expression 
differs when induced acutely by MeHg versus Notch (Fig. 1-3) (Rand et al., 2008). 
Treatment of cells with the calcium chelator ethylenediaminetetraacetic acid (EDTA) 
causes cleavage of Notch expressed on the cell surface, releasing the intracellular domain 
and stimulating the Notch pathway through endogenous Notch protein (Rand et al., 
2008). The effects on the E(spl) locus of treatment with MeHg were compared to 
endogenous Notch activity stimulated with EDTA using quantitative real-time 
polymerase chain reaction (qPCR). It was found that Notch primarily causes upregulation 
of the E(spl) m3 and m7 genes with modest increases in m2, mγ, and mβ; importantly the 
mδ gene shows very little upregulation due to endogenous Notch activity (Rand et al., 
2008). MeHg treatment caused upregulation primarily in the mδ and mγ genes, with little 
upregulation of m3 (Rand et al., 2008). If MeHg was acting through Notch to cause its 
upregulation of E(spl) genes, it would be expected that MeHg and EDTA treatments 
would cause upregulation of the same genes. Because the mδ gene shows little expression 
due to endogenous Notch activity but is highly upregulated due to MeHg treatment we 





 The effect of MeHg on E(spl) genes is not exclusive to Drosophila. Studies using 
rat neural stem cells (NTCs) indicate that MeHg can inhibit NTC differentiation (Tamm 
et al., 2008). This failure to differentiate was correlated with an increase in Notch activity 
measured by increased cleavage of the Notch intracellular domain (Tamm et al., 2008). 
Pretreatment with a Notch cleavage inhibitor reversed the repression of neuronal 
differentiation due to MeHg treatment (Tamm et al., 2008). While these findings seem to 
indicate that MeHg acts in a Notch dependant manner in rat NTCs it has yet to be seen if 
a shorter time course of MeHg treatment relieves the Notch dependence, as has been 
shown in Drosophila cell lines. 
 
1.4: The Drosophila embryo 
 Drosophila melanogaster is an important model organism for the study of 
developmental pathways and processes. It was in Drosophila that the Notch pathway was 
first described, and Drosophila remains one of the best models in which to study Notch 
signaling and other fundamental signaling pathways. There are three principle advantages 
of the Drosophila model. First, it is well studied; the literature contains a wealth of 
information on the genomics, genetics, transcriptomics, and proteomics that describe an 
organism. Second, there exist a plethora of tools to utilize in Drosophila. Compared to 
mammalian models it is easy to create transgenic animals; the gal4/UAS system allows 
previously created transgenics to be combined into new driver/responder pairs, allowing 
fast an efficient exploration of gene/tissue interactions (Fig. 1-4). Finally the Drosophila 





rapid advancement and quick replication of experiments. Ease of storage removes the 
need for expensive animal facilities and staff. 
 Additionally, Drosophila are exceptionally well suited for evaluation of 
developmental toxicity. The developmental timeline of the embryo is well-established 
(Fig. 1-5). The size and abundance of embryos allows immunostaining of whole mounts 
with large samples for each experiment. Exposure of the embryos is also simplified in 
Drosophila as many toxins, such as MeHg, diffuse readily into embryos that have had the 
chorion membrane removed (Fig. 1-6). 
 
Motor Nerve Pattern and Guidance 
The development and anatomy of motor nerves in the Drosophila embryo has 
been well studied and is easily accessible using immunofluorescent staining of whole 
mounted embryos, making it a good model of neurodevelopment. Each abdominal 
hemisegment of the embryo has two major motor nerves that emerge from the ventral 
nerve cord, the intersegmental nerve (ISN) and segmental nerve (SN) (Fig. 1-7). The ISN 
has three branches, the ISNa, ISNb, and ISNd (Kaufmann et al., 1998; Sun et al., 2001). 
ISNa projects dorsally to innervate muscles in the dorsal field, including the dorsal 
oblique and dorsal acute muscles (Kaufmann et al., 1998; Sun et al., 2001). The ISNb/d 
both terminate in the ventral muscle field and innervate muscles including the ventral 
longitudinal group (Kaufmann et al., 1998; Sun et al., 2001). The SN has two major 
branches, the SNa and SNc (Kaufmann et al., 1998; Sun et al., 2001). The SNa itself has 
a characteristic branching pattern, innervating the lateral transverse muscles with its 





1998; Sun et al., 2001). The SNc innervates ventral muscle groups (Kaufmann et al., 
1998; Sun et al., 2001). 
 Axon outgrowth in these motor nerves has been well studied. There is evidence 
that pioneer neurons establish the path for other axons to follow, though there is 
remarkable resilience to ablation of these pioneers (Lin et al., 1995; Sanchez-Soriano and 
Prokop, 2005). Fasciculin II (FasII) is the major adhesive molecule that maintains 
fasciculation in the nerve fiber; higher FasII expression levels in the pioneer neurons 
have been shown to cause them to grow ahead of other contributing neurons, establishing 
the path of the nerve (Sanchez-Soriano and Prokop, 2005). Specifically, FasII loss of 
function in the ISN pioneers, the aCC and RP2 neurons, causes them to lose their ability 
to influence nerve outgrowth (Sanchez-Soriano and Prokop, 2005). Increasing expression 
of FasII in follower neurons causes them to exert increased influence on the direction of 
nerve outgrowth (Sanchez-Soriano and Prokop, 2005). 
The guidance cues for motor axon outgrowth have only recently been elucidated. 
It has been shown that during outgrowth the motor nerves contact glia, sensory nerves, 
and muscle cells expressing Sidestep (Side), a transmembrane immunoglobulin 
superfamily protein, in a tightly controlled temporospatial pattern (Fig. 1-8) (Aberle, 
2009b, a; Siebert et al., 2009). Each of these tissues expresses Side only while they are in 
the immediate path of the motor nerves, turning off expression as the growth cone 
contacts and then passes them (Aberle, 2009b, a; Siebert et al., 2009). In Side mutants 
axons fail to defasciculate, indicating that Side acts in opposition to FasII to cause 
branching of motor axons (Aberle, 2009b, a; Siebert et al., 2009). Similarly, perturbation 





al., 1999a). Mesodermal expression of the active Notch intracellular domain causes 
failure to develop muscle founder cells, which organize the fusion of muscle fibers 
(Landgraf et al., 1999a). Without muscle fibers to express Side motor axons fail to 
defasciculate (Landgraf et al., 1999a). The protein Beaten path Ia (Beat) has been shown 
to be the receptor for Side signals (Aberle, 2009b, a; Siebert et al., 2009). Beat is 
expressed on motor nerve growth cones and has been shown to interact with Side 
(Aberle, 2009b, a; Siebert et al., 2009). Beat mutants show motor axon defasciculation 
failure similar to Side mutants (Aberle, 2009b, a; Siebert et al., 2009). Additionally, 
unlike wild type axons, Beat mutants fail to follow ectopic Side expression (Aberle, 
2009b, a; Siebert et al., 2009). These data indicate that Side/Beat act as the primary 
attractive cues guiding motor axon outgrowth in embryos. 
If Side/Beat are the directors of motor axon outgrowth, actin assembly in the 
growth cone is the driving force behind it (Kaufmann et al., 1998). Evidence indicates 
that the Rho-family GTPases Dcdc42 and Drac1 play important roles in organization of 
the actin cytoskeleton in response to guidance cues (Kaufmann et al., 1998). Neuronal 
expression of dominantly activated versions of either Dcdc42 or Drac1 causes arrest of 
motor nerve outgrowth consistent with a disruption of leading edge motility (Kaufmann 
et al., 1998). Dominant negative expression of the two reveal differences in function, 
however; Dcdc42 dominant negative expression causes some axons to fail to reach their 
most distal targets, whereas Drac1 dominant negative expression causes changes in the 
trajectory of the axons but no change in outgrowth (Kaufmann et al., 1998). Both of these 
phenotypes can be mimicked pharmacologically utilizing cytochalasin D to block actin 





Other molecules have also been shown to play important roles in axon outgrowth, 
though the mechanisms of their action are less well defined. Five receptor-linked protein 
tyrosine phosphatases, DPTP10D, DLAR, DPTP69D, DPTP99A, and DPTP52F are 
expressed in embryonic Drosophila axons (Desai et al., 1997; Schindelholz et al., 2001; 
Sun et al., 2001). Mutation analysis of these proteins indicates that they interact in a 
variety of cooperative, redundant, or competitive ways depending upon cellular context 
to contribute to motor nerve outgrowth and guidance (Desai et al., 1997; Schindelholz et 
al., 2001; Sun et al., 2001). Mutation of these phosphatases, both individually and in 
combination, can cause a variety of phenotypes in motor nerves including axon stalling, 
failure to synapse, failure to form branches, and formation of additional branches (Desai 
et al., 1997; Schindelholz et al., 2001; Sun et al., 2001). What role in axon outgrowth 
these phosphatases play during normal development is still a matter of speculation. 
The Notch pathway has also been shown to play a role in motor axon outgrowth. 
It has been shown that Notch and Delta expression during outgrowth are necessary for 
development of the ISN (Giniger et al., 1993; Crowner et al., 2003). Experiments 
utilizing flies expressing a temperature-sensitive Notch allele have shown that removal of 
Notch during outgrowth of the ISNb causes the axons to bypass their normal pathway, 
remaining adhered the ISNa rather than branching (Crowner et al., 2003). Data indicates 
that during normal axon outgrowth Notch protein expressed on the axon growth cone 
suppresses activity of the Abl tyrosine kinase in a noncanonical mechanism that does not 
involve Su(H) or E(spl)s; as the Abl pathway normally causes adhesion of the axons this 
suppression of Abl by Notch allows the ISNb to defasciculate from the ISNa (Crowner et 





across segments in the central nervous system have revealed similar Notch/Abl 
interactions resulting in decreased adhesion of axons to the substratum they grow across, 
allowing motility (Kuzina et al., 2011). Additional studies have shown that mutation of 
the Notch pathway regulator Endonuclease GI (EndoGI) causes failure of motor axons to 
innervate their appropriate muscle targets; this may indicate that EndoGI is active in the 
Notch/Abl signaling described in other work (O'Keefe et al., 2010). In cultured 
embryonic mouse neurons Notch has been shown to play the opposite role; increased 
Notch activity in these cells causes decreased neurite outgrowth (Sestan et al., 1999). The 
mechanisms for this decrease in outgrowth have not been elucidated. Combined these 
data indicate a complex, context-dependent role for Notch in neurite outgrowth. 
 
1.5: Summary and significance 
MeHg is a potent environmental toxin that strongly influences neural 
development. Though MeHg has been shown to impact a variety of cellular processes, 
the mechanism of its neurodevelopmental specificity is not yet fully understood. 
Experiments have shown that MeHg causes upregulation of canonical Notch-response 
genes in the E(spl) complex. Because of the crucial role of the Notch pathway in neural 
development the changes in Notch target expression elicited by MeHg may be an 
important mediator of the neurodevelopmental specificity of MeHg. 
In this dissertation I hypothesize that overexpression of the E(spl) gene mδ plays a 
critical role in MeHg toxicity in Drosophila. To test this I will first establish that MeHg 





will then identify a neural phenotype of MeHg treatment in Drosophila embryos and 
show that I am able to replicate it using genetic manipulation of E(spl)mδ. 
The findings of this dissertation will support a role for the Notch pathway target 
E(spl)mδ in MeHg toxicity, suggesting there be further study of the impact of MeHg on 
E(spl) homologues in mammals. Additionally, my work will show that impacts on muscle 
development can mediate the effect of MeHg on neural development; supported by the 
previous work showing a glial impact of MeHg toxicity in mammals this finding suggests 
that the neurodevelopmental specificity of MeHg may not be due to direct impacts on 
neurons but instead on supporting tissues. Overall this work suggests new avenues of 











Figure 1 - 1. Schematic of the Enhancer of Split complex. 







Figure 1 - 2. Schematic of the Notch signaling pathway. 
Notch expressed on the cell receiving the signal binds its ligand, expressed on the cell sending the signal. 
After ligand binding ADAMs cleave the extracellular domain of the Notch protein from the 
transmembrane/intracellular domains. Presenilin then cleaves the intracellular domain from the 
transmembrane domain. The free Notch intracellular domain enters the cell nucleus where it binds to 
Suppressor of Hairless [Su(H)], allowing dissociation from corepressors. Notch then recruits coactivators 

























Figure 1 - 3. Methylmercury and Notch signaling show different fingerprints of E(spl) upregulation. 
In the Drosophila neural-derived cell line bg2-c6, following MeHg treatment or Notch cleavage through 
treatment with EDTA the relative expression levels of E(spl) complex genes were assayed via qPCR. The 
figure shows relative fold change over untreated controls normalized to the RP49 housekeeping gene. 














































Figure 1 - 4. Schematic of the GAL4/UAS exogenous expression system in Drosophila. 
The GAL4/UAS system is widely used in Drosophila to drive expression of genes of interest under the 
control of a promoter of interest. Female flies carrying a construct in which a driver of interest drives 
expression of the yeast transcription factor GAL4 are bred with males carring a construct in which the yeast 
upstream activator sequence (UAS) drives expression of a gene of interest. In cells where GAL4 is 

















Figure 1 - 5. Stages of Drosophila embryo development. 
Anterior is left and dorsal is up. Neuroblasts (light purple, at stage 8-11). Ventral nerve cord (VNC) and 
brain neurons (purple, at St. 12-17).  Endoderm/midgut (red).  Mesoderm (green). Foregut/Hindgut (Blue). 
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Figure 1 - 6. Methods for in vitro exposure of Drosophila embryos to toxins. 
Embryos collected from adults laying on grape-agar plates are dechorionated in dilute bleach. Embryos are 
then placed in baskets designed to optimize air exposure while being immersed in a solution containing the 
toxin of interest. After a period of developmental exposure, embryos can then be processed for RNA 

























Figure 1 - 7. Image and schematic of motor nerves in the embryo. 
A) Immunostaining embryos with αFasII antibody reveals the motor nerves. The intersegmental nerve 
(ISN) has three main branches, the ISNa (labeled ISN), the ISNb, and the ISNd. The segmental nerve (SN) 
has two major branches, the SNa and SNc. The SNa itself has a characteristic branch near its terminal so it 
can innervate both the lateral transverse muscles and segmental border muscle. B) An illustration of the 
motor nerves and the muscles they innervate in one hemisegment, showing genes specifically expressed in 







Figure 1 - 8. Temporospatial regulation of Sidestep guides motor axon pathfinding. 
Guidepost cells in the direct path of the developing embryonic motor axon express Sidestep (Side), an 
attractive cue. The axon growth cones express Beaten path Ia (Beat), the receptor for Side. It is the 
carefully timed expression of Side in the cells the axon must next grow towards that guides motor nerve 
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CHAPTER 2: THE EFFECTS OF METHYLMERCURY ON NOTCH 
SIGNALING DURING EMBRYONIC NEURAL DEVELOPMENT IN 
DROSOPHILA MELANOGASTER 
 
Material from this chapter has been published in the following form: 
Engel GL, Delwig A, Rand MD (2012) The effects of methylmercury on Notch signaling 






Methylmercury (MeHg) is a ubiquitous toxicant that targets the developing fetal nervous 
system.  MeHg interacts with the Notch signaling pathway, a highly-conserved 
intercellular signaling mechanism required for normal development.  Notch signaling is 
conveyed by activation of the genes in the Enhancer of Split (E(spl)) locus in Drosophila.  
We have previously shown that acute high doses of MeHg upregulate several E(spl) 
genes in Drosophila neural-derived C6 cells.  Furthermore, MeHg induction of E(spl) can 
occur independent of the Notch receptor itself.  We now show that MeHg, unlike 
inorganic mercury (HgCl2), preferentially upregulates E(spl)mδ and E(spl)mγ in 
Drosophila C6 cells.  This is distinct from Delta ligand-induced Notch signaling in which 
no induction of E(spl)mδ is seen. MeHg is also seen to specifically upregulate E(spl)mδ 
in Drosophila embryos where HgCl2 showed no such effect. Additionally, treatment of 
embryos with MeHg caused a consistent failure in axonal outgrowth of the 
intersegmental nerve (ISN). This ISN phenotype was partially replicated by genetic 
activation of the Notch pathway, but was not replicated by increasing expression of 
E(spl)mδ. These data suggest a role for Notch signaling and the E(spl)mδ target gene in 




Methylmercury (MeHg) is a ubiquitous environmental toxin that preferentially 
targets the developing nervous system.  Because of its apparent specificity for neural 





toxicity. Several studies in both mammalian and invertebrate systems now support the 
hypothesis that the Notch pathway is a potential target for MeHg.  Notch is a fundamental 
cell-cell signaling pathway that directs cell fate decisions during neurogenesis. Being first 
elucidated in Drosophila, it is now well understood that signals through Notch receptors 
cause activation of downstream effectors; those of the Enhancer of Split [E(spl)] gene 
locus in flies and the Hairy/Enhancer of Split (HES) genes in mammals (de-la-Concha et 
al., 1988; Preiss et al., 1988; Jarriault et al., 1998). The E(spl) locus in flies consists of 11 
genes in a single 50kb locus. Seven of these E(spl) genes, E(spl)mδ, E(spl)mγ, E(spl)mβ, 
E(spl)m3, E(spl)m5, E(spl)m7, and E(spl)m8, are basic helix-loop-helix transcriptional 
repressors. While different E(spl) genes are known to be preferentially expressed in 
various developing tissues, manipulations in Drosophila demonstrate that all the E(spl) 
genes are capable of responding to Notch signals (Jennings et al., 1999; Nellesen et al., 
1999; Wech et al., 1999; Wurmbach et al., 1999). Signals at the level of the Notch 
receptor are propagated by cleavage and activation by members of the ADAM family of 
metalloproteases. The potential for MeHg to stimulate ADAM activity initially led to the 
hypothesis that MeHg could ultimately induce Notch signals (Bland and Rand, 2006). 
This was supported by evidence that E(spl)mγ and E(spl)mβ show a dose-dependent 
increase in transcription with MeHg applied to Drosophila neural cells in culture (Bland 
and Rand, 2006).  In subsequent studies we have shown that stimulation of E(spl) genes 
in Drosophila cells by MeHg can occur despite knockdown of Notch receptor expression 
(Rand et al., 2008).  These observations suggest MeHg can act through a more direct 





In this study, using MeHg exposures to Drosophila C6 neural derived cells in 
culture in addition to exposures of the whole animal at various developmental stages, we 
confirm a specific action of MeHg toward the E(spl)mδ gene. We also demonstrate that 
E(spl)mδ, in stark contrast to the other E(spl)s, is not responsive to Notch signals 
propagated by its cognate ligand, Delta, in the C6 neural cell line, allowing us to 
elucidate the MeHg specific action on this gene target. A specific effect of MeHg relative 
to inorganic mercury (HgCl2) in E(spl)mδ activation is observed in C6 cells and in 
embryos, however, mercury induction of E(spl)mδ was not seen at later developmental 
stages. MeHg treated embryos exhibit an overt defect in formation of the intersegmental 
nerve (ISN). Increasing Notch pathway activity in neurons by driving expression of the 
Notch intracellular domain (NICD) under the control of the pan-neural elav promoter 
causes a similar defect in ISN outgrowth, however driving expression of E(spl)mδ in 
neurons did not elicit an ISN phenotype. 
Our findings indicate that MeHg specifically effects E(spl)mδ in vitro and in vivo 
during Drosophila embryogenesis. Our data shows specificity in gene activation by 
MeHg compared to other stressors, such as HgCl2, highlighting the potential for E(spl)mδ 
to mediate some MeHg-induced changes in developmental signaling in the embryo. 
However, neuron-specific expression of E(spl)mδ did not replicate a characteristic ISN 
MeHg phenotype, which could be partially replicated with neuron-specific Notch 
activation.  These results point to novel non-canonical Notch pathway mechanisms that 








Drosophila bg2-c6 cells (C6 cells), a neural cell line obtained from the 
Drosophila Genomics Resource Center (Ui et al., 1994) were cultured in Shields and 
Sang M3 medium with added bactopeptone and yeastolate (BPYE), supplemented with 
bovine serum, insulin, and penicillin/streptomycin at 25°C in a humidified incubator. 
 
Cell culture mercury treatments: 
Stock solutions of methylmercury (MeHg chloride, Aldrich 442534) and mercury 
chloride (HgCl2, Sigma-Aldrich 215465) were prepared in dimethyl sulfoxide (DMSO) at 
50mM.  Mercury treatments were made at concentration ranging from 0-100µM. DMSO 
concentration was adjusted to be equivalent across control and mercury treatments and 
never exceeded 0.1% DMSO.  Cells were plated at 80% confluence in standard medium 
and allowed to adhere and recover for one hour. They were then washed three times with 
M3 medium lacking serum or antibiotics (M3-) and the medium was replaced with M3- 
with added mercury or DMSO control. Cells were treated for three hours, after which the 
medium was removed and cells were harvested for either RNA extraction with Trizol 
reagent (Invitrogen) or viability assays were performed. 
 
Cell viability assay: 
Cell viability was determined by dual staining with calcein and ethidium using the 
LIVE/DEAD Viability/Cytotoxicity Kit for mammals (Invitrogen) as per product 





3hr, then treated with 2µM calcein AM and ethidium homodimer and incubated for 
30min. Cells were washed, then plated and counted for green and red cells. Breakdown of 
calcein AM by esterases causes green fluorescence and marks living cells, while 
disruption of cell membranes in death allows permeability to ethidium homodimer 
causing nuclear red fluorescence. The ratio of green to red cells, normalized to control 
cell treatments and treatments eliciting 100% cell death, were used to determine the 
measure of cell viability. (n>150 cells per single treatment across seven concentrations). 
 
Fly stocks and crosses: 
Unless otherwise stated, fly stocks were maintained on standard cornmeal-yeast-
molasses food at 25°C. Lines used include Canton S, elav-GAL4 (Bloomington 
Drosophila Stock Center, #458), UAS-Notchintra (gift from Cedric Wesley, University of 
Wisconsin Laboratory of Genetics), and UAS-E(spl)mδ (Bloomington Drosophila Stock 
Center, #26677). Standard crosses were performed between virgin female Gal4 driver 
lines and male UAS responder lines to generate F1 progeny to be tested. 
 
Embryo mercury treatments: 
Cages of adult flies were allowed to lay eggs on a grape agar plate with yeast 
paste smeared on the center. (See Fig. 2-4) Unless stated otherwise the embryo collection 
occurred over a two hour laying period. Embryos were then aged on the grape plates at 
25°C; standard aging time was two hours. Embryos were dechorionated using a standard 
protocol. Briefly, embryos were washed from the plate using tap water and a brush into a 





sodium hypochlorite) for three minutes, then rinsed in tap water to remove bleach. 
Embryos were transferred to separate nytex baskets for each treatment, which were in 
turn placed into petri dishes containing phosphate buffered saline (PBS) with added 
mercury or DMSO control. These dishes were covered to prevent evaporation and the 
embryos were allowed to incubate for 16-18 hours or various times where indicated. A 




Immunostaining was performed as previously described (Rand et al., 2009). 
Treated embryos were fixed in 500 µL of a 50:50 mix of 8% paraformaldehyde in 0.1 M 
PIPES, 2 mM EGTA, 1 mM MgSO4, pH 6.9 (PEM) with heptane by rocking for 25 min. 
Vitelline membranes were subsequently removed by discarding the lower PEM layer and 
adding 750 mL MeOH, then vortexing for 30 s. Settled embryos were collected, washed 
and stored at -20C in methanol until staining. For immunostaining, embryos were 
permeablized in phosphate buffered saline (PBS) with 1% BSA, 0.1% triton X-100 
(PBT). Subsequent blocking, primary and secondary antibody incubations were done in 
PBT with 5% each of donkey and goat serum. Primary antibodies used were: mouse anti-
elav (9F8A9), mouse anti-notch (9C6), and rat anti-FasII (1D4) (Obtained from the 
Developmental Studies Hybridoma Bank, Univ. of Iowa). Secondary antibodies used 
were: Alexa488-conjugated goat anti-rat and Alexa555-conjugated goat anti-mouse 
(Jackson ImmunoResearch). Embryos were visualized by fluorescence microscopy on a 





acquisition software (MVI, Avon, MA). Images were assembled in Adobe Photoshop, 
GIMP, and Microsoft PowerPoint. 
 
RNA Extraction and quantitative PCR: 
After mercury treatments, embryos were transferred with a paintbrush into 
microcentrifuge tubes containing PBS supplemented with 0.1% Triton-X and 1% bovine 
serum albumin (PBT). The PBT was removed with a pipette and replaced with Trizol 
reagent (Invitrogen). Embryos were homogenized in Trizol and processed for RNA 
isolation. RNA samples were treated with Turbo DNAse (Ambion) and reversed 
transcribed using SSII reverse transcriptase (Invitrogen). RNA was subsequently 
removed with RNAse H (USB).  cDNA samples were assayed for gene expression via 
qRT-PCR using SybrGreen dye (Bio-Rad). Data were normalized to the ribosomal 
protein RP49 housekeeping gene and analyzed using the comparative Ct method (Livak 
and Schmittgen, 2001). Primer sequences for E(spl)mδ, E(spl)mγ, E(spl)mβ, E(spl)m2, 
E(spl)m3, E(spl)m7, Notch, and the RP49 control were taken from (Rand et al., 2008). 
The sequences used for Hsp70Ab were Forward: 
TGAGAGTGATAAGAATGTTTCGAT and Reverse: 
AGTCTACAAAACATTAAATGACCAAGTT. For Hsp70Bc the sequences were 









Larval and adult mercury treatments: 
Embryos collected from an overnight laying in a population cage were transferred 
to bottles of standard cornmeal-molasses food supplemented with 15 µM MeHg or 
DMSO (control). Embryos were allowed to develop until they reached the late third instar 
wandering stage (approximately 4 days). At this stage they were harvested and disrupted 
for RNA isolation using an RNeasy mini kit (Qiagen). 
Adult flies were cultured for three days on food containing concentrations of 
MeHg up to 100µM. The flies were then frozen using liquid nitrogen and broken apart 
using a vortexer. Heads were collected using a sieve and subsequently homogenized in 
Trizol reagent. RNA transcript levels were assayed by qRT-PCR as described above.  
 
2.4: Results 
We have previously demonstrated an ability of MeHg to induce E(spl) gene 
expression in cultured Drosophila C6 cells (Rand et al., 2008).  In this previous study 
EDTA was used as a proxy to invoke Notch signaling in C6 cells for comparative effects 
on E(spl) expression.  Since notable differences between EDTA-induced and MeHg-
induced E(spl) activation was observed, we wished to further validate these effects with 
respect to Notch signaling.  To examine Notch signaling explicitly we co-cultured the C6 
cells on fixed preparations of cells expressing Delta, the endogenous ligand of the Notch 
receptor, in a previously established assay in our laboratory (Delwig and Rand, 2008). 
We then analyzed E(spl) expression exclusively in the Notch expressing cells via qRT-
PCR (Fig. 2-1).  This treatment caused the greatest induction of E(spl)mβ and E(spl)m3 





upregulated by Delta induced Notch signaling.  Overall, Delta induced Notch signaling 
under these conditions gives a similar pattern of E(spl) induction as was seen with EDTA 
earlier (Rand et al., 2008) indicating this profile is representative of Notch signaling in 
this cell line.  
 We next sought to compare MeHg effects with inorganic mercury to determine if 
the E(spl) activation profile of MeHg is unique or shares properties with other mercurials. 
We first determined levels of toxicity of MeHg and HgCl2 toward C6 cells.  Cell viability 
subsequent to MeHg and HgCl2 exposures was determined using dual calcein/ethidium 
staining (Fig. 2-2). A dose dependent decrease in cell viability was observed with MeHg, 
which proved more potent than HgCl2.  MeHg exhibited an approximate 20% cell death 
(80% viability) at 4µM and an approximate 50% reduction in viability at 20µM.  HgCl2 
proved weaker showing an approximate 20% reduced viability at 20µM and 50% reduced 
viability with 100µM HgCl2. Similar results were obtained using alternative 
determinations with Trypan Blue reagent (Data not shown).  These doses were 
implemented in subsequent assays of acute exposure effects on E(spl) activation.  
 With MeHg treatment of C6 cells E(spl)mδ, E(spl)mγ, and E(spl)m7 showed the 
greatest fold-induction (7 to 12-fold, Fig. 2-3) of six representative E(spl) genes spanning 
the E(spl) locus. E(spl)mβ and E(spl)m3 showed less substantial increases (less than 4-
fold) with MeHg treatment, while E(spl)m2 approached a 6-fold induction.  In contrast, 
cells treated with HgCl2 showed less than 3-fold response in E(spl)mδ and E(spl)mγ, and 





with a nearly 9-fold change with 100µM MeHg (Fig. 2-3).  These data show a differential 
response of individual genes in the E(spl) locus with MeHg versus HgCl2 exposure. 
 The apparent unique effect of MeHg on E(spl) gene expression in vitro prompted 
us to investigate similar effects in vivo. We have previously established an ability to dose 
Drosophila embryos with MeHg cultured in vitro (Rand et al., 2009). This methodology 
is summarized in Figure 2-4.  The method takes advantage of the unique property that fly 
embryos denuded of their outer chorion layers of the eggshell are permeable to MeHg 
and are also able to continue development suspended in a defined culture media (see 
methods and Figure 2-4).  Using this technique we evaluated the dose-response of 
embryos to MeHg by assaying gene expression using qRT-PCR and monitoring the 
response of a ubiquitous stress response gene, Hsp70. The Hsp70 Bc gene showed a 
robust increase in expression with increasing levels of MeHg, confirming the entry of the 
MeHg in embryonic tissues (Fig. 2-5). In parallel we probed E(spl)mδ gene expression 
which was seen to increase across all concentrations of MeHg.  A more than seven-fold 
increase in E(spl)mδ was seen at 20µM MeHg, which appeared to be sustained at 50µM 
MeHg.  From these data we chose to treat embryos with 50µM MeHg in subsequent 
analyses to ensure we were above a threshold in effect. 
 To assess the level of specificity with which MeHg acts on embryonic tissues we 
again compared E(spl) expression response to MeHg versus HgCl2 treatment (Fig. 2-6). 
After MeHg, treatment (50µM) E(spl)mδ consistently showed greater than three-fold 
upregulation in embryos across several trials. In contrast, none of the other E(spl) genes 
assayed showed a response to MeHg in embryos treated in vitro.  In addition, Notch 





E(spl)mδ could not stem from increased receptor expression. An induction of two Hsp70 
genes Hsp70Ab and Hsp70Bc was observed for MeHg, again confirming entry of the 
toxicant into the embryos.  Treatment of embryos with 1mM HgCl2 did not cause any 
increase in E(spl) gene expression.  In contrast, a modest decrease was seen in levels 
across all the E(spl) genes and Notch after HgCl2 treatment. Upregulation of Hsp70 genes 
after HgCl2 treatment indicated that the dose of HgCl2 used showed a similar degree of 
entry and overall toxic insult to that of MeHg. These data indicate that MeHg acts 
selectively on E(spl)mδ transcription in Drosophila embryos. 
 E(spl) gene expression is known to change over the course of embryogenesis 
(Tweedie et al., 2009).  Recent data from gene expression arrays performed within the 
large scale ModEncode project (Tweedie et al., 2009) and publically available on Flybase 
(Graveley et al.) permit a comprehensive analysis of developmental expression of the 
E(spl) gene during normal embryogenesis. Transcript levels of E(spl)mδ, E(spl)mγ, and 
E(spl)m7  show a similar profile as Notch, which shows a peak of expression at 6-8 hours 
of development after egg laying (Fig. 2-7).  In contrast, E(spl)m3 shows peak expression 
discernibly later, peaking at 8-10 hours AEL. The bell-shaped expression of the E(spl) 
genes prompted us to test whether the effect of MeHg on increasing E(spl)mδ in embryos 
was simply due to a developmental delay and shift in peak of gene expression versus an 
ectopic induction of gene expression.  To achieve this we incubated batches of 
developmentally staged embryos with or without MeHg for various treatment intervals, 
and compared E(spl) expression via qRT-PCR.  In untreated embryos the overall profile 





course of embryogenesis.  For E(spl)mδ, E(spl)mγ, and E(spl)m7 a peak of expression 
between 6-8 hours after egg laying (AEL) was observed (Fig. 2-8).  For E(spl)m3 this 
peak was seen between 8-10 hours AEL. Notch expression showed a gradual decline over 
the course of embryogenesis.  With MeHg treatment, E(spl)mδ showed higher expression 
at each time point after 6hr AEL compared to untreated embryos, with more than 2-fold 
higher expression at the 8-10hr interval.  Peak expression remained at the 6-8 hour AEL 
interval with MeHg, indicating the developmental delay was not substantial at this time 
point. Higher expression due to MeHg was not consistently observed for E(spl)mγ and 
E(spl)m3, while E(spl)m7 did show modest increases at time points after 8hrs AEL with 
MeHg treatment. Notch showed no consistent difference in expression due to MeHg 
treatment over these developmental periods (Fig. 2-8).  Hsp70 Bc, like E(spl)mδ, showed 
increased expression due to MeHg treatment at every time point, confirming the access of 
MeHg to embryonic tissues at all stages. 
 Observing that E(spl)mδ is upregulated in embryos after MeHg treatment we 
investigated whether or not the MeHg effect was penetrant at later developmental stages. 
First instar (L1) larvae were cultured on food containing 15µM MeHg and harvested for 
qRT-PCR after reaching the wandering third instar (L3) stage.  Previous analyses have 
demonstrated that treatment of larvae with 15µM MeHg shows similar toxicity to 50µM 
treatments of embryos (Rand et al., 2009; Mahapatra et al.). We then examined global 
transcript levels of E(spl)s and Notch from whole larval extracts using qRT-PCR (Fig. 2-





observed. These data suggest that Drosophila tissues at later developmental stages than 
the embryo are refractory to MeHg induced expression of E(spl).  
 To further test whether the effect of MeHg on E(spl)mδ expression is specific to 
the embryo we tested E(spl) expression responses to MeHg in adult flies. Adult 
Drosophila were cultured for three days on food containing various concentrations of 
MeHg up to 100µM. RNA transcript levels in extracts prepared from isolated heads were 
assayed by qRT-PCR. We opted to examine this tissue since Notch activity and E(spl) 
expression is a strong determinant in neural tissues and the fly head is rich in brain tissue. 
We determined that no consistent changes in E(spl)mδ, or any of the E(spl) genes 
examined, were seen with MeHg treatments (data not shown). Altogether, the data from 
larval and adult assays indicate that the global effect of MeHg on E(spl)mδ expression is 
specific to embryos. 
 We next turned to examining the embryonic nervous system for phenotypes that 
characteristically reflected MeHg insult to development.  Our previous studies have 
identified several features in the embryo CNS and PNS that reflect compromised 
development with MeHg exposure (Rand et al., 2009). Notably, neurite outgrowth of 
CNS and PNS axons visualized in the lateral field of the late stage embryo has been seen 
to be compromised (Rand et al., 2009). Using an antibody specific to the ISN, a bundle of 
four axons of central motor neurons, we observed that these axons frequently failed to 
develop properly in MeHg treated embryos (Fig. 2-10). This phenotype of MeHg 
exposure presents as stunted or misguided ISNs in treated embryos (Fig. 2-10 D-F) and is 





in the lateral field (Fig. 2-10 F).  Interestingly, previous studies have identified a role for 
Notch signaling in the appropriate projection of the ISN neuron (Giniger et al., 1993). 
We therefore set out to test whether genetic manipulations of Notch in general, 
and E(spl)mδ in particular, could mirror effects of MeHg on ISN development.  We first 
examined the effect of ubiquitous activation of Notch in post mitotic neurons by driving 
expression of NICD under control of the pan-neural elav promoter using the GAL4/UAS 
system (see methods). Ectopic expression of NICD in neurons could be detected with an 
antibody to the NICD (Fig. 2-11 A-C) and by qRT-PCR. In general, the potent activity of 
Notch was evident by an overall failure of a substantial number of embryos to develop to 
late stages.  Of those that were able to develop to late stage a common feature was seen in 
a stunted outgrowth of the ISN (Fig. 2-11 D-F) akin to that seen with MeHg treatment.  
As E(spl)mδ was the most consistent E(spl) responder to MeHg we next determined if 
E(spl)mδ overexpression by the elav promoter could elicit an analogous MeHg-like ISN 
phenotype. Despite unambiguous overexpression of E(spl)mδ in elav-GAL4>UAS-
E(Spl)mδ embryos (as determined by qRT-PCR, as no E(spl)mδ antibodies are available) 
no apparent phenotype in ISN development was observed (Fig. 2-11 G-I).  
 
2.5: Discussion 
In this study we have shown that MeHg causes an upregulation of E(spl)mδ  in 
Drosophila neural cells and, importantly, in embryos treated in vitro.  This effect is 
specific to MeHg and does not occur with inorganic mercury. This E(spl)mδ specific 





activation by the Delta ligand in the C6 neural cell line.  MeHg elicits a characteristic 
failure in ISN axon outgrowth that, to some extent, can be induced with neural 
overexpression of Notch activity. However, targeted E(spl)mδ expression in neurons has 
no effect on ISN development.  A role for E(spl)mδ in mediating MeHg effects via non-
neuronal cells remains to be investigated.  Altogether, these data highlight a novel and 
specific action for MeHg to target induced expression of a neurogenic signaling gene in 
conjunction with elicited neural developmental phenotypes.  
 E(spl) genes, are basic helix-loop-helix (bHLH) transcriptional repressors. These 
bHLH genes are the main effectors of Notch signaling in the nervous system, acting to 
repress transcription of proneural genes and generally preventing a default neuronal 
differentiation program from occurring. While various E(spl) genes have different 
expression patterns there is enough redundancy in expression and function to make 
discerning phenotypes difficult if only one E(spl) gene is perturbed. Nonetheless, 
E(spl)mδ siRNA injection in Drosophila embryos results a neurogenic phenotype, albeit 
with low frequency, consistent with a perturbation of Notch signaling (Nagel et al., 
2004). The low penetrance of phenotypic effects of E(spl)mδ perturbation predict that its 
contribution to MeHg effects in the embryo will be subtle.  It is thus not surprising that 
genetic manipulation of E(spl)mδ exclusively in neurons is not sufficient to replicate the 
MeHg-induced ISN phenotype. That genetic manipulation of the Notch pathway can 
replicate this phenotype suggests that there may be a central role for the Notch pathway 
in MeHg toxicity, potentially through the additive effects on E(spl)mδ and other E(spl) 





MeHg toxicity but also reveal unique mechanisms for the differential expression of E(spl) 
genes. 
 Our findings suggest that induction of E(spl)mδ by MeHg in vivo is restricted to 
the embryonic stage. This observation is consistent with the notion that cellular defense 
mechanisms (e.g. glutathione pathway) are not fully developed in early embryogenesis, 
as compared with the differentiated larval and adult tissues.  This outcome grossly 
mimics the preferential toxicity of MeHg for the fetus versus adult in higher organisms.  
Alternatively, differences may stem from our method of administration of the MeHg, 
which differ between our embryonic and larval/adult treatments: larvae and adult flies 
consume MeHg with the food, and may be able to mitigate toxicity via the gut.  In 
contrast, embryos are soaked in MeHg medium allowing for more direct contact with 
embryonic cells. Yet, at the doses used, larvae show similar lethality as embryos 
(Mahapatra et al.).  Assuming that embryo-specific induction of E(spl)mδ is not related to 
the route of MeHg administration it may help elucidate the mechanism for the specific 
neurodevelopmental toxicity in mice and humans.  
In summary, we demonstrate that MeHg causes increased expression of E(spl)mδ 
in vivo in Drosophila embryos. We also demonstrated that while E(spl)mδ transcript 
upregulation correlates with MeHg neuronal phenotypes in embryos, E(spl)mδ 
overexpression restricted to neurons is not sufficient to replicate this characteristic axon 
outgrowth phenotype, pointing to a non-neuronal activity of E(spl)mδ in this toxicity 
model.  These findings set the stage for investigating novel mechanisms of MeHg toxicity 
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Figure 2 - 1. E(spl) gene expression in Delta ligand induced Notch signaling. 
Organization of the Enhancer of split (E(spl)C) locus is diagramed and select genes analyzed in this study 
are indicated with a  “check mark”. Delta induced E(spl) expression was determined with a previously 
described co-culture assay (Delwig and Rand, 2008). Briefly, S2 cells stably expressing the Notch ligand 
Delta (Dl-S2 cells) or control S2 parent cells lacking the ligand were cultured as a monolayer then 
stabilized through brief fixation. C6 cells, which express Notch endogenously, but not the Delta ligand, 
were then co-cultured with either the fixed Dl-S2 cells or control S2 cells. E(spl) gene expression was 
measured via qRT-PCR. Data represent the fold change in E(spl) expression in C6 cells due to Delta 
exposure,  Error bars indicate standard deviation. (n=6 (m2, m3, m7, mδ) to 12 (mβ and mγ) independent 
experimental determinations,  * = p<0.01 by Student’s t-test). 













Figure 2 - 2. Cell viability of Drosophila neural-derived cells after mercurial treatment. 
Drosophila C6 cells were treated for three hours with various doses of  MeHg or HgCl2. Viability was 





























Figure 2 - 3. E(spl) gene induction by mercurial treatment. 
Drosophila C6 cells were treated for three hours with the indicated concentrations of MeHg or HgCl2. 
E(spl) gene expression determined by qRT-PCR is expressed in fold change over control treatments. (n = 3 



































































Figure 2 - 4. A schematic representation of in vitro dosing of Drosophila embryos with toxins. 
Embryos collected from adults laying on grape-agar plates are dechorionated in dilute bleach. Embryos are 
then placed in baskets designed to optimize air exposure while being immersed in a solution containing the 
toxin of interest. After a period of developmental exposure, embryos can then be processed for RNA 

























Figure 2 - 5. Dose response of E(spl)mδ in Drosophila embryos after MeHg treatment. 
Drosophila embryos (2-4 hours after egg laying) were dechorionated and soaked in buffer containing 
indicated concentration of MeHg for 16 hours. Gene expression for E(spl)mδ and the stress-response gene 
Hsp70 Bc determined by qRT-PCR is expressed in fold change over 0 µM MeHg treatments. (n>300 

























Figure 2 - 6. E(spl) gene induction in Drosophila embryos after mercurial treatment. 
Drosophila embryos 2-4 hours after egg laying were soaked overnight in buffer containing 50µM MeHg or 
1mM HgCl2. Gene expression determined by qRT-PCR is expressed in fold change over control treatments.  
Values are the mean (and SEM) of three independent treatments of embryo batches (n = 3 independent 


































Figure 2 - 7. Relative gene expression levels of select E(spl) genes and Notch during embryonic 
development. 
Relative gene expression levels determined through the Mod Encode project (Graveley et al.) were adapted 
from FlyBase (Tweedie et al., 2009) and expressed graphically to allow comparison of peak expression 
timing. E(spl)mδ, E(spl)mγ, and E(spl)m7 coincide with Notch peak expression at 6-8 hours after egg 






Figure 2 - 8. Response of E(spl) genes in Drosophila embryos after MeHg treatment over the course 
of development. 
Drosophila embryos were dechorionated and soaked in buffer containing 50µM MeHg for indicated 
lengths of time. Gene expression determined by qRT-PCR is expressed in fold change over control 
treatments for A) E(spl)mδ, B) E(spl)mγ, C) E(spl)m3, D) E(spl)m7, E) Notch, and F) HSP70 Bc. (Each 
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Figure 2 - 9. E(spl) gene induction in Drosophila larvae after MeHg treatment. 
Drosophila embryos were placed on standard cornmeal-molasses food containing 15µM MeHg or DMSO 
vehicle control. Development was allowed to progress to the late third instar larvae stage. Larvae were then 
homogenized, RNA extracted and gene expression determined by qRT-PCR, expressed in fold change over 
control treatments. (Error bars indicate standard deviation of three experimental replicates. No significant 










































































































































































































































































Figure 2 - 11. Notch pathway activation in neurons disrupts nerve outgrowth in embryos that is not 
induced with E(spl)mδ overexpression. 
A-C) Embryos driving expression of the Notch intracellular domain (NICD), the active component of the 
Notch receptor, under control of elav show notch immunoreactivity in neurons. D-F) elav> NICD embryos 
stained for FasII (D) and elav (E) demonstrate stunted outgrowth of the ISN (arrow head). G-I) Embryos 
with targeted expression of the E(spl)mδ gene in neurons stained for FasII (G) and elav (H) show normal 
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CHAPTER 3: THE EFFECTS OF METHYLMERCURY ON THE NOTCH 
SIGNALING PATHWAY AND MOTOR NERVE FORMATION DURING 
DROSOPHILA EMBRYONIC DEVELOPMENT 
 
3.1: Abstract 
 Methylmercury (MeHg) is a ubiquitous environmental toxin. It is known that 
MeHg has a potent impact on neural development, but the mechanisms for this 
neurodevelopmental specificity are unknown. Previous work in our lab has shown that in 
Drosophila embryos MeHg causes upregulation of a canonical Notch response gene 
E(spl)mδ. In this study we hypothesize that this change in E(spl)mδ contributes to the 
toxicity of MeHg in the embryo. We test this by exogenously overexpressing E(spl)mδ in 
the embryo in an attempt to replicate a phenotype observed in the motor nerves following 
MeHg treatment. Our experiments show that E(spl)mδ, but not the closely related gene 
E(spl)mγ, can mimic the MeHg phenotype; however, the MeHg-like phenotype is only 
elicited when E(spl)mδ is overexpressed in developing muscles and not neurons as we 
originally predicted. Interestingly, we show that E(spl)mδ is endogenously expressed in 
developing muscle. This work shows not only that E(spl)mδ plays an important role in 
MeHg toxicity in the Drosophila embryo, but also that MeHg is capable of causing 




 Methylmercury (MeHg) is an environmental contaminant that causes toxicity 
during human neural development. Though large exposures can be prevented, low dose 





many populations. Contemporary epidemiological studies into the effects of this exposure 
on children and fetuses have shown mixed results (Grandjean et al., 1995; Myers et al., 
1995; Rice, 2004). As such, it is important that we investigate the mechanisms of MeHg 
toxicity so that we can formulate evidence-driven strategies to minimize the risk MeHg 
poses to human health. 
 Previous work in our lab has shown that MeHg causes transcriptional 
upregulation of the Enhancer of Split [E(spl)] complex gene E(spl)mδ in the embryonic 
Drosophila model organism (Bland and Rand, 2006; Rand et al., 2008; Engel et al., 
2012). The E(spl) complex is a group of 13 canonical Notch response genes; E(spl)mδ is 
one of several basic helix-loop-helix (bHLH) transcriptional repressors best known as 
effectors of Notch signaling (Portin, 2002). Because Notch signaling is central in cell fate 
determination in the neurectoderm we hypothesized that this induction of E(spl)mδ by 
MeHg is important in MeHg toxicity and may contribute to its neurodevelopmental 
specificity. 
 To investigate this possibility we sought a readily quantifiable neural phenotype 
of MeHg toxicity in the embryos. Previous work in our lab had shown some deficits in 
neural patterning and migration following MeHg treatment of embryos (Rand et al., 
2009). In this study we evaluate discernable defects in embryonic motor neuron axon 
outgrowth that result from MeHg treatment. Motor nerve development in the Drosophila 
embryo has been well characterized in the literature and follows a segmentally repeating 
easily indentified pattern (Kaufmann et al., 1998; Murray et al., 1998; Landgraf et al., 
1999b; Sun et al., 2001; Sanchez-Soriano and Prokop, 2005). There are two major motor 





projecting segmental nerve (SN). The ISN is characterized by a single long fiber that 
emerges from the ventral nerve cord and travels in a predominantly straight path to the 
dorsal muscle field, synapsing with muscles along its path. The SN emerges from the 
ventral nerve cord and immediately curves toward the lateral transverse (LT) muscle 
group, forming a characteristic branch in order to innervate both the LT muscles and the 
segmental border muscle (SBM). The pattern and development of muscles are similarly 
well studied. All muscles in the Drosophila embryo begin with the selection of muscle 
founder cells, which then fuse with a population of nearby fusion competent cells to form 
multinucleated muscle fibers (Olson et al., 1995; Maqbool and Jagla, 2007; Tixier et al., 
2010). This recruitment and fusion by the muscle founder cells forms a segmentally 
repeated muscle pattern. Among the field of several muscle groups the pattern of the four 
LT muscles can be clearly observed as a cluster of parallel fibers. 
 In this study we maintain our hypothesis that E(spl)mδ plays an important role in 
MeHg neurotoxicity. Staining for motor nerves in MeHg-treated embryos using 
antibodies specific to the fasciculin II (FasII) adhesion molecule we observed a failure of 
the ISN to project past lateral sensory neurons stained with a neural specific marker 
(Elav) (Engel et al., 2012). We attempted to replicate this phenotype by overexpressing 
E(spl)mδ in neurons, but did not observe any changes in ISN axon projection (Engel et 
al., 2012)., We subsequently found E(spl)mδ is endogenously expressed in developing 
muscle cells. By manipulating E(spl)mδ in developing muscle we observe a significant 
impact on motor nerve outgrowth. Additionally, we demonstrate a specificity of E(spl)mδ 
as a possible effector of MeHg toxicity by comparing it to the closely related E(spl) gene 





findings show that MeHg is likely to influence nervous system development via gene 
expression in supporting tissues and, furthermore, that E(spl)mδ plays a crucial role in 
muscle, rather than neural, development. 
 
3.3: Materials and Methods 
Fly stocks and crosses: 
 Unless otherwise stated, fly stocks were maintained on standard cornmeal-yeast-
molasses food at 25°C. Fly strains used include Canton S, elav-GAL4 (Bloomington 
Drosophila Stock Center, #458), Mef2-gal4 (gift from Jim Vigoreaux, University of 
Vermont), UAS-nuclearGFP (Bloomington Drosophila Stock Center, #4775), UAS-
E(spl)mδ (Bloomington Drosophila Stock Center, #26677), UAS-E(spl)mδRNAi (Vienna 
Drosophila RNAi Center, #13077), E(spl)mγ-lacZ (gift from Sarah Bray, University of 
Cambridge (Cooper et al., 2000)), and UAS-E(spl)mγ (gift from Christos Delidakis, 
University of Crete (Ligoxygakis et al., 1999)). Standard crosses were performed 
between virgin female Gal4 driver lines and male UAS responder lines to generate F1 
progeny to be tested. 
 
Generation of E(spl)mδ-GFP reporter strain: 
 The 5kb upstream E(spl)mδ promoter region was amplified from genomic DNA 
via PCR using Phusion DNA polymerase (New England Biolabs) to include restriction 
endonuclease sites at each end (XbaI at 5’, KpnI at 3’) with the following primers: 
Forward: gaTCTAGAgtaaattacagccacttgaag, Reverse: gaGGTACCgtagctgctggtgccgtac. 





Pelican (Barolo et al., 2000) by cleaving both with XbaI and KpnI (New England 
Biolabs) and ligating with T4 DNA ligase (New England Biolabs) (Fig. 3-2). Bacterial 
transformation was performed with One Shot TOP10 chemically competent cells 
(Invitrogen) according to manufacturer’s instructions. Bacteria were then plated on LB 
agar plates containing ampicillin to select for transformants. Transformed colonies were 
grown and the plasmid purified using a Qiagen maxiprep kit. The plasmid was verified to 
ensure proper construction by DNA sequencing (Vermont Cancer Center DNA Analysis 
Core Facility). Transgenic flies were created by P-element mediated germline 
transformation (BestGene Inc). 
 
Embryo mercury treatments: 
 Cages of adult flies were allowed to lay eggs on a grape agar plate with yeast 
paste smeared on the center. Embryo collection occurred over a two hour laying period. 
Embryos were then aged on the grape plates at 25°C for two hours. Embryos were 
dechorionated using a standard protocol. Briefly, embryos were washed from the plate 
using tap water and a brush into a nytex basket, then rinsed to remove yeast; baskets were 
transferred to 50% bleach (~3.8% sodium hypochlorite) for three minutes, then rinsed in 
tap water to remove bleach. Embryos were transferred to separate nytex baskets for each 
treatment, which were in turn placed into petri dishes containing modified basic insect 
medium with added mercury or DMSO control. These dishes were covered to prevent 








 Immunostaining was performed as previously described (Rand et al., 2009). 
Treated embryos were fixed in 500 µL of a 50:50 mix of 8% paraformaldehyde in 0.1 M 
PIPES, 2 mM EGTA, 1 mM MgSO4, pH 6.9 (PEM) with heptane by rocking for 25 min. 
Vitelline membranes were subsequently removed by discarding the lower PEM layer and 
adding 750 mL MeOH, then vortexing for 30 s. Settled embryos were collected, washed 
and stored at -20C in methanol until staining. For immunostaining, embryos were 
permeablized in phosphate buffered saline (PBS) with 1% BSA, 0.1% triton X-100 
(PBT). Subsequent blocking, primary and secondary antibody incubations were done in 
PBT with 5% each of donkey and goat serum. Primary antibodies used were: mouse anti-
elav (9F8A9), rat anti-FasII (1D4) (Developmental Studies Hybridoma Bank, Univ. of 
Iowa), rabbit anti-GFP (Torrey Pines Biolabs, Inc), rabbit anti-βgal (Chemicon 
International), and rabbit anti-myosin (gift from Daniel Kiehart, Duke University). 
Secondary antibodies used were: Alexa488-conjugated goat anti-rat, Alexa555-
conjugated goat anti-mouse, and Alexa555-conjugated goat anti-rabbit (Jackson 
ImmunoResearch). Embryos were visualized by fluorescence microscopy on a Leitz 
Orthoplan 2 microscope equipped with a Spot One digital camera and associated 
acquisition software (MVI, Avon, MA). Phenotypes were scored per hemisegment 
looking exclusively at abdominal segments 1-5. Images were assembled in Adobe 








RNA extraction and quantitative PCR: 
 After mercury treatments, embryos were transferred with a paintbrush into 
microcentrifuge tubes containing PBS supplemented with 0.1% Triton-X and 1% bovine 
serum albumin (PBT). The PBT was removed with a pipette and replaced with Trizol 
reagent (Invitrogen). Embryos were homogenized in Trizol and processed for RNA 
isolation. RNA samples were treated with Turbo DNAse (Ambion) and reversed 
transcribed using SSII reverse transcriptase (Invitrogen). RNA was subsequently 
removed with RNAse H (USB).  cDNA samples were assayed for gene expression via 
qRT-PCR using SybrGreen dye (Bio-Rad). Data were normalized to the ribosomal 
protein RP49 housekeeping gene and analyzed using the comparative Ct method (Livak 
and Schmittgen, 2001). Primer sequences for E(spl)mδ and the RP49 control were taken 
from (Rand et al., 2008). The sequences used for Sidestep were Forward: 
GCGGCGGATATTAGGGCACGG and Reverse: CGGGTCGTTTAGGCTGGGCT. For 




 In a previous study we identified a phenotype of MeHg treatment in embryos in 
the ISN (Engel et al., 2012). Additional observations identified a second phenotype of 
MeHg treatment in embryonic motor nerves visualized with α-FasII antibodies; MeHg 
treated embryos show a significant failure of branching in the SN (Fig. 3-1). This branch 
failure was not observed to favor the development of one branch over the other; 





point were all observed with approximately equal frequency (data not shown). This SN 
phenotype is more readily observed than the ISN phenotype, as it requires staining of 
only the nerve itself and no additional marker. It is also easily quantified as individual 
segments can be clearly identified as branching or failing to branch. We therefore utilized 
this SN phenotype to elaborate MeHg effects in this study. 
 We have previously shown that overexpressing E(spl)mδ in neurons fails to cause 
any changes in ISN outgrowth (Engel et al., 2012). We therefore analyzed endogenous 
E(spl)mδ expression to discern where it might be acting in normal development. 
Transgenic flies expressing an E(spl)mδ-GFP reporter construct show a similar pattern to 
expression of GFP under control of the muscle-specific Mef2-gal4 driver, indicating that 
endogenous expression of E(spl)mδ in embryos is in the muscle (Fig. 3-2). 
 We endeavored to determine whether we could replicate the effects of MeHg 
treatment on SN branching by overexpression of E(spl)mδ in embryos. When 
overexpressed in muscle, where it is endogenously expressed, using the Mef2-gal4 driver 
E(spl)mδ causes a significant failure in SN branching (Fig. 3-3). Overexpression of 
E(spl)mδ in neurons by Elav-gal4, however, did not cause increased SN branch failure 
(Fig. 3-3). These data suggest that overexpression of E(spl)mδ in the substrata on which 
the nerves elaborate, but not the nerves themselves, causes failure of proper axonal 
outgrowth, mimicking that seen with MeHg treatment. 
 Seeing that E(spl)mδ overexpression in muscle caused a SN phenotype similar to 
MeHg we wanted to determine whether either of these treatments grossly impacted 
muscle development. We stained the muscles of MeHg treated, Mef2>mδ, and control 





3-4). To assess normal development we evaluated the morphology of the lateral 
transverse muscles 1-4 (LT 1-4), known targets of the SN. Among control embryos only 
1% of hemisegments observed showed a defect by the inability to identify each of the 
four (Fig. 3-4 A). MeHg treated embryos showed disorganization of the muscle pattern, 
with unidentifiable LT 1-4 in 15% of hemisegments (Fig. 3-4 B). Mef2>mδ embryos 
showed even higher rates of muscle pattern failure, showing a disordered muscle 
phenotype in 58% of hemisegments (Fig. 3-4 C). These data correlate with the SN 
phenotype, which is more prevalent in Mef2>mδ embryos than those treated with MeHg 
(Fig. 3-1, 3-3). 
 We wished to further investigate the relationship between the phenotypes we 
observed in the SN and muscle. We co-stained MeHg treated and Mef2> mδ embryos for 
FasII and myosin and looked at the coincidence of SN and muscle failure. Though 
muscle phenotype was a significant predictor of SN phenotype it predicted only 84.4% of 
the SN phenotype data correctly (binary logistic regression; n = 225; p < 0.001). In MeHg 
treated embryos over 13% of the hemisegments quantified showed a SN phenotype but 
no muscle phenotype, while nearly 12% showed a muscle phenotype but no SN 
phenotype (Fig. 3-5). This indicates that factors other than gross muscle pattern play a 
role in SN failure in our experiments. 
 It has been shown that interaction between Side expressed in the path of the 
developing SN and Beat expressed in the axon growth cones plays an important role in 
SN guidance during development (Siebert et al., 2009). We hypothesized that changes in 
expression of these signaling molecules due to MeHg treatment or overexpression of 





expression levels of these signaling factors using qPCR on RNA extracted from whole 
embryos treated with MeHg or overexpressing E(spl)mδ by Mef2-gal. This analysis 
showed no significant change in expression of either gene in either treatment compared to 
controls (Fig. 3-6). 
 In addition to looking at potential causes of the SN phenotype we observed after 
MeHg treatment and E(spl)mδ upregulation in muscle we endeavored to determine 
whether this effect was specific to E(spl)mδ or a common effect to other E(spl) genes. 
We have previously shown that E(spl)mγ responds to MeHg treatment of Drosophila cell 
lines (Rand et al., 2008). Though it does not respond to MeHg treatment in embryos, 
E(spl)mγ is closely related to E(spl)mδ, and lies immediately downstream on the 
chromosome (Wurmbach et al., 1999; Engel et al., 2012). In order to use E(spl)mγ as a 
tool to look at the specificity of E(spl)mδ in the SN phenotype we first wanted to confirm 
its endogenous expression pattern. mγ-lacZ flies stained for βgal and Elav show that 
expression of E(spl)mγ largely restricted to neural cells in the embryo (Fig. 3-7). 
 In order to test whether E(spl)mγ could replicate the SN phenotype caused by 
E(spl)mδ overexpression in muscle we drove expression of E(spl)mγ using the same 
Mef2-gal4 driver line; no increase in the SN phenotype over controls was seen (Table 1). 
Additionally, we attempted to drive expression of E(spl)mγ in neurons, where it is 
endogenously expressed, to see what effect this might have on motor nerve development. 
However, this cross proved lethal at early stages of embryonic development, preempting 








 We have shown that MeHg treatment in embryos causes failure of axon 
outgrowth in the SN. When E(spl)mδ is overexpressed in muscle, where it is 
endogenously expressed, but not the neurons themselves we see similar SN phenotypes. 
In both MeHg treated and E(spl)mδ overexpressing embryos we see disruption of muscle 
development, but we were unable to measure changes in expression of guidance cues 
known to be expressed by the muscle. These phenotypes do not occur when another 
E(spl), E(spl)mγ is overexpressed. 
 The combined results of these experiments lead us to a new model of how MeHg 
interferes with embryonic development to impact the nervous system (Fig. 3-8). In this 
model MeHg enters the cells of the embryo and through an as-of-yet unknown 
mechanism causes the upregulation of E(spl)mδ. Though this upregulation may occur in 
several tissue types it is in muscle progenitors that it has the greatest effect, causing 
failure of the muscle to form normal patterns. E(spl)mδ overexpression in neurons does 
not produce an observable phenotype, but perturbation of muscles by E(spl)mδ 
upregulation influences the outgrowth of motor neurons. E(spl)mδ may also impact 
muscle cells in other ways, such as disruption of the precise timing, but not overall 
expression level, of Side that is necessary for motor nerve guidance. 
This model proposes that MeHg-induced E(spl)mδ expression is not influencing 
nervous system development by directly affecting neurons, but instead affecting 
supporting cells required for the normal development of those neurons. Other labs have 
found evidence that MeHg toxicity may be mediated by the effect of MeHg on glia 





development should analyze whether MeHg acts directly on neurons or rather on 
supporting cells in the system studied. 
The earliest and best studied role of the Notch pathway is in cell fate 
determination of the neurectoderm. Like many highly conserved signaling pathways, 
though, Notch is involved in many different processes. It has been shown that 
components of the Notch pathway influence mesoderm development (Vasyutina et al., 
2007). Our work reinforces this literature by demonstrating a role for E(spl)mδ in the 
formation of muscle patterning. Additional evidence for the important role of E(spl)mδ in 
mesoderm development comes from experiments where we attempted to knockdown 
E(spl)mδ expression using an RNAi strain driven by Mef2-gal4. This cross proved lethal 
early in embryonic development [data not shown], which combined with the knowledge 
that E(spl)mδ is endogenously expressed in the muscle and that overexpressing E(spl)mδ 
causes disorganization of the muscle pattern indicates a critical role for E(spl)mδ in 
mesoderm development.  
Contrasting overexpression of E(spl)mδ with E(spl)mγ provides some additional 
clues on the observed specificity in the response of E(spl)mδ to MeHg treatment. When 
E(spl)mγ is overexpressed in tissues where it is found endogenously it proves lethal to the 
embryo; when E(spl)mδ is overexpressed in a pattern mimicking its endogenous 
expression embryos show a distinct phenotype, but develop to late embryonic stages and, 
in fact, hatch into larvae at levels comparable to controls [data not shown]. One possible 
explanation for this is that MeHg causes increased expression of both E(spl)mδ and 
E(spl)mγ at variable levels in different embryos, and our observation that only E(spl)mδ 





lethality of embryos in which E(spl)mγ is upregulated in neurons. This seems unlikely, 
however, as qPCR is a relatively sensitive measure of RNA transcript level, and E(spl)mγ 
transcript will necessarily increase before the E(spl)mγ protein that presumably causes 
lethality. A more interesting explanation for why E(spl)mδ and not E(spl)mγ is 
upregulated is that because it is more lethal when overexpressed E(spl)mγ is more tightly 
regulated by the embryo than E(spl)mδ. Evidence supporting this hypothesis could be 
obtained by overexpressing other closely related E(spl) genes that do not respond to 
MeHg treatment of embryos, such as E(spl)m3 or E(spl)m7, and measuring lethality in 
the embryos; should these other E(spl) genes prove lethal when overexpressed it may 
indicate that E(spl)mδ is uniquely benign among E(spl) genes, allowing it to be less 
tightly regulated than other E(spl)s and thus more responsive to MeHg. 
 
3.6: Conclusion 
 MeHg is characterized in the literature as a toxin that most potently impacts 
neural development. In our Drosophila embryo model we observed effects of MeHg on 
neural development, specifically in the outgrowth of motor axons. However, further 
investigation into the observed motor nerve phenotype revealed that it is MeHg toxicity 
affecting the muscles that causes the failure in nerves. Further experiments suggested by 
this finding include investigating the precise interaction between muscle and nerve that is 
impacted by MeHg treatment. This finding should also inform future research into MeHg 
toxicity in general; where possible steps should be taken to analyze the effect of MeHg 
on all tissues likely to impact the system being studied. Though MeHg toxicity in 





continue to investigate the impacts of MeHg on other tissues and the contributions that 
might have to the observed neural phenotypes. 
 Our data continue to support an important role for E(spl)mδ in MeHg toxicity in 
the Drosophila embryo, showing that E(spl)mδ specifically, and not the closely related 
E(spl)mγ, can replicate a neural phenotype of MeHg treatment. We have also provided 
evidence that E(spl)mδ is active primarily in the mesoderm during embryonic 
development, rather than the neuroectoderm where Notch targets play their canonical 
role. Further work investigating the molecular mechanisms by which MeHg effects 
E(spl)mδ upregulation may provide valuable insight into MeHg toxicity, but also the 







3.7: Tables and Figures 
 
 
Table 3 - 1. Overexpression of E(spl)mγ does not cause branch failure in the SN. 
Mef2-gal4 female flies were crossed with UAS-mγ males, producing offspring that overexpress E(spl)mγ 
in mesoderm (Mef2>mγ). Mef2>mγ embryos at stage 14/15 were fixed and stained with αFasII and 
compared to control embryos (Mef2>GFP). SN failure rate was the same in both groups. UAS-mγ was also 
crossed with Elav-gal4, producing Elav>mγ overexpressing E(spl)mγ in neurons. This cross proved lethal, 
and embryos did not develop beyond early stages. Each n is a single abdominal segment, A1-5, in which 
the segmental nerve was seen to develop normally (Normal) or failed to branch (Failed). (n = 100 segments 
per treatment) 
 
  Normal % Failed % 
Mef2>GFP (100) 93 7 









Figure 3 - 1. MeHg treatment significantly alters SN branching. 
Drosophila embryos 2-4 hours AEL were soaked overnight in buffer containing 50µM MeHg or DMSO 
control. They were then fixed and stained with αFasII. Only embryos that developed to stage 14/15 were 
used for quantification. Each n is a single abdominal segment, A1-5, in which the segmental nerve was 
seen to develop normally (Normal) or failed to branch (Failed). Red arrows indicate SN branch failure. (n = 
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Figure 3 - 2. E(spl)mδ is endogenously expressed in mesodermal tissues in the Drosophila embryo. 
Transgenic mδ-GFP reporter flies were created with the plasmid shown (see methods). Expression of the 
green fluorescent protein (GFP) reporter in the transgenic flies shows a pattern similar to GFP expressed 
under the control of a known mesodermal driver (Mef2) using the GAL4/UAS expression system. 
 

















Figure 3 - 3. Overexpression of E(spl)mδ in mesoderm significantly alters SN branching, replicating 
the MeHg induced phenotype. 
Mef2-gal4 female flies were crossed with UAS-mδ males, producing offspring that overexpress E(spl)mδ 
in mesoderm (Mef2>mδ). Mef2>mδ embryos at stage 14/15 were fixed and stained with αFasII and 
compared to control embryos (Mef2>GFP). UAS-mδ was also crossed with Elav-gal4, producing Elav>mδ 
overexpressing E(spl)mδ in neurons. These were compared with the Elav-gal4 driver line. Each n is a single 
abdominal segment, A1-5, in which the segmental nerve was seen to develop normally (Normal) or failed 
to branch (Failed). Red arrows indicate SN branch failure. (n = 200 (Mef2>mδ) or 100 (Mef2>GFP, 






Mef2>GFP (n = 100)
93.0% 7.0%
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Figure 3 - 4. MeHg treated and Mef2>mδ embryos show a disorganized muscle pattern. 
Drosophila embryos 2-4 hours AEL were soaked overnight in buffer containing 50µM MeHg or DMSO 
control (50µM MeHg and Control). These were compared to similarly aged untreated embryos 
overexpressing E(spl)mδ in muscles (Mef2>mδ). Embryos were fixed and stained with αmyosin. Only 
embryos that developed to stage 14/15 were used for quantification. Each n is a single abdominal segment, 
A1-5, in which the lateral transverse muscles 1-4 were observed to determine if they had developed 
sufficiently to be identifiable or were so disorganized as to be unidentifiable. Red arrows indicate 
unidentifiable muscles. (n = 100 segments per treatment; * = p<0.001 by Fisher’s exact test for the 
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Figure 3 - 5. SN and muscle phenotypes do not always co-occur. 
Drosophila embryos 2-4 hours AEL were soaked overnight in buffer containing 50µM MeHg or DMSO 
control. They were then fixed and stained with αFasII (red) and αmyosin (green). Only embryos that 
developed to stage 14/15 are shown. Images were obtained from either MeHg treated or control embryos 
and show that each combination of SN and muscle phenotypes occurred. MeHg treated embryos were 
scored by a blinded scorer to record the presence of SN and/or muscle phenotypes for each abdominal  
hemisegment, A1-5. Data show the percentage of scored hemisegments showing each phenotype 
combination. (n = 75) 
 











Figure 3 - 6. Expression of known guidance cues is not altered by MeHg treatment or E(spl)mδ 
overexpression. 
RNA was harvested from groups of whole Drosophila embryos treated with 50µM MeHg and compared to 
DMSO treated controls or overexpressing E(spl)mδ in muscles (Mef2>mδ) and compared to Mef2>GFP 
embryos. Data shown are the fold induction of gene expression over appropriate controls for the treated 







































Figure 3 - 7. E(spl)mγ is expressed in the nervous system. 
Embryos from an E(spl)mγ-lacZ fly strain were double stained for βgal (red), which should express where 





































Figure 3 - 8. Working model of MeHg toxicity in Drosophila embryos. 
Our current model for how MeHg affects Drosophila embryos to produce phenotypes in motor nerves. 
A) MeHg enters cells in the embryo and binds to an unknown factor, X. B) The MeHg-Factor X 
complex causes upregulation of E(spl)mδ, but is unable to cause upregulation of E(spl)mγ or other 
E(spl) genes. C) In neurons this upregulation does not cause pathological changes, but in muscles 
overexpression of E(spl)mδ causes failures that lead to improper/incomplete development. These 
changes in muscle ultimately lead to an inability of motor axons, which normally receive important 






Barolo S, Carver LA, Posakony JW (2000) GFP and beta-galactosidase transformation 
vectors for promoter/enhancer analysis in Drosophila. BioTechniques 29:726, 728, 730, 
732. 
Bland C, Rand MD (2006) Methylmercury induces activation of Notch signaling. 
Neurotoxicology 27:982-991. 
Cooper MT, Tyler DM, Furriols M, Chalkiadaki A, Delidakis C, Bray S (2000) Spatially 
restricted factors cooperate with notch in the regulation of Enhancer of split genes. 
Developmental biology 221:390-403. 
Engel GL, Delwig A, Rand MD (2012) The effects of methylmercury on Notch signaling 
during embryonic neural development in Drosophila melanogaster. Toxicol In Vitro. 
Grandjean P, Weihe P, White RF (1995) Milestone development in infants exposed to 
methylmercury from human milk. Neurotoxicology 16:27-33. 
Kaufmann N, Wills ZP, Van Vactor D (1998) Drosophila Rac1 controls motor axon 
guidance. Development 125:453-461. 
Landgraf M, Roy S, Prokop A, VijayRaghavan K, Bate M (1999b) even-skipped 
determines the dorsal growth of motor axons in Drosophila. Neuron 22:43-52. 
Ligoxygakis P, Bray SJ, Apidianakis Y, Delidakis C (1999) Ectopic expression of 
individual E(spl) genes has differential effects on different cell fate decisions and 
underscores the biphasic requirement for notch activity in wing margin establishment in 
Drosophila. Development 126:2205-2214. 
Maqbool T, Jagla K (2007) Genetic control of muscle development: learning from 
Drosophila. J Muscle Res Cell Motil 28:397-407. 
Murray MJ, Merritt DJ, Brand AH, Whitington PM (1998) In vivo dynamics of axon 
pathfinding in the Drosophilia CNS: a time-lapse study of an identified motorneuron. 
Journal of neurobiology 37:607-621. 
Myers GJ, Davidson PW, Cox C, Shamlaye CF, Tanner MA, Marsh DO, Cernichiari E, 
Lapham LW, Berlin M, Clarkson TW (1995) Summary of the Seychelles child 
development study on the relationship of fetal methylmercury exposure to 
neurodevelopment. Neurotoxicology 16:711-716. 
Olson EN, Perry M, Schulz RA (1995) Regulation of muscle differentiation by the MEF2 
family of MADS box transcription factors. Developmental biology 172:2-14. 
Portin P (2002) General outlines of the molecular genetics of the Notch signalling 





Rand MD, Bland CE, Bond J (2008) Methylmercury activates enhancer-of-split and 
bearded complex genes independent of the notch receptor. Toxicol Sci 104:163-176. 
Rand MD, Dao JC, Clason TA (2009) Methylmercury disruption of embryonic neural 
development in Drosophila. Neurotoxicology 30:794-802. 
Rice DC (2004) The US EPA reference dose for methylmercury: sources of uncertainty. 
Environ Res 95:406-413. 
Sanchez-Soriano N, Prokop A (2005) The influence of pioneer neurons on a growing 
motor nerve in Drosophila requires the neural cell adhesion molecule homolog 
FasciclinII. J Neurosci 25:78-87. 
Shanker G, Allen JW, Mutkus LA, Aschner M (2001) Methylmercury inhibits cysteine 
uptake in cultured primary astrocytes, but not in neurons. Brain research 914:159-165. 
Siebert M, Banovic D, Goellner B, Aberle H (2009) Drosophila motor axons recognize 
and follow a Sidestep-labeled substrate pathway to reach their target fields. Genes Dev 
23:1052-1062. 
Sun Q, Schindelholz B, Knirr M, Schmid A, Zinn K (2001) Complex genetic interactions 
among four receptor tyrosine phosphatases regulate axon guidance in Drosophila. 
Molecular and cellular neurosciences 17:274-291. 
Tixier V, Bataille L, Jagla K (2010) Diversification of muscle types: recent insights from 
Drosophila. Exp Cell Res 316:3019-3027. 
Vasyutina E, Lenhard DC, Birchmeier C (2007) Notch function in myogenesis. Cell 
cycle (Georgetown, Tex 6:1451-1454. 
Wurmbach E, Wech I, Preiss A (1999) The Enhancer of split complex of Drosophila 







CHAPTER 4: SUMMARY AND CONCLUSIONS 
 
 MeHg is a potent environmental neurotoxin that shows particular toxicity during 
neural development. Exposure to low doses of MeHg through fish and other seafood has 
shown variability in effects on fetuses and children in a number of population studies, 
inconsistently resulting in subtle behavioral and developmental deficits (Rice, 2004). Due 
to the importance of seafood in the diet of many peoples and the near ubiquitous 
contamination by MeHg, exposure to this toxin is inevitable. It is therefore crucial to 
improve our understanding of the mechanisms involved in MeHg toxicity, so that we 
might find ways to advise the public on ways to avoid any adverse effects of MeHg 
exposure. 
 The studies in this dissertation advance the understanding of MeHg toxicity 
primarily through dissecting its interaction with the neurogenic Notch signaling pathway. 
The Notch pathway is known to be involved with development and differentiation of 
many tissues, but plays its most prominent role in neural development (Portin, 2002). It 
has been previously shown that MeHg treatment in neural-derived Drosophila cell lines 
causes upregulation of the gene E(spl)mδ, a canonical Notch target, independent of Notch 
receptor protein itself (Rand et al., 2008). Because the Notch pathway is so highly 
involved in development of the nervous system I hypothesized that this change in 
E(spl)mδ expression plays an important role in the neurodevelopmental specificity of 
MeHg toxicity, and as such plays a role in MeHg toxicity in general. 
 Data from my studies show that MeHg treatment in vivo in embryos causes the 
same characteristic upregulation of E(spl)mδ as it does in cultured cell lines. This is 





of the system being studied, and is not mitigated by the resilience of a whole organism. 
My findings also show that this effect on E(spl)mδ is specific to MeHg, and can not be 
replicated by the inorganic mercurial HgCl2 at doses showing similar toxicity. 
Establishing the specificity of MeHg to induce this effect is crucial in showing it is not a 
more generic response to stress or toxicity, which would indicate E(spl)mδ does not play 
a role in defining the neurodevelopmental specificity of MeHg. Further, my studies 
establish that this effect of MeHg on E(spl)mδ is not due to overall developmental delay 
in the embryos. Though gross developmental delay is a plausible mechanism for MeHg to 
cause toxicity it would have indicated that E(spl)mδ was simply a read-out of MeHg 
exposure, and not an important effector of MeHg toxicity. (Engel et al., 2012) 
 Though my experiments provide evidence for a specific upregulation of E(spl)mδ 
by MeHg, they do not indicate the mechanism that causes this effect. In my working 
model of MeHg toxicity I suggest that this upregulation is caused by binding of MeHg to 
an unidentified factor, X, with the MeHg/X complex driving expression of E(spl)mδ. I 
believe that Factor X belongs to one of two classes of proteins, traditional transcription 
factors or epigenetic regulators. If X is a traditional transcription factor it would have to 
be one that binds the promoter of E(spl)mδ but not other E(spl) genes, as the other E(spl)s 
are not upregulated by MeHg treatment in vivo. One plausible mechanism is that binding 
of MeHg might alter the activity of the factor X, either in preventing normal activity of a 
repressor or stimulating binding of an enhancer. A more thorough analysis of regulators 
of E(spl) gene transcription might then reveal the identity of X. Factor X might also be an 
epigenetic regulator of gene expression, such as a histone or histone deacetylase. If this is 





affecting access of the regulatory sequences controlling expression of E(spl)mδ. As in the 
case of X being a traditional transcription factor if X is an epigenetic regulator it will 
necessarily interact with E(spl)mδ but not other E(spl) genes. As such identification of X 
could be accomplished using techniques such as chromatin immunoprecipitation and 
comparing the factors that associate with different E(spl)s to identify one that interacts 
only with E(spl)mδ. 
 After establishing that E(spl)mδ is affected by MeHg in vivo I sought to identify 
an appropriate phenotype of MeHg neural toxicity to determine whether E(spl)mδ is 
involved. Utilizing immunofluorescence and referring to the abundant literature on 
Drosophila development I identified phenotypes of MeHg treatment in the outgrowth and 
pathfinding of motor nerves in the embryo. This finding provided an accessible model of 
MeHg neural toxicity, which I probed to determine if genetic manipulation of E(spl)mδ 
replicates MeHg-induced phenotypes. Unexpectedly, driving expression of E(spl)mδ in 
neurons showed no discernable phenotype. I was then guided by the endogenous 
expression of E(spl)mδ, which showed expression localized to muscle during embryonic 
development. Overexpression of E(spl)mδ in muscle does cause a MeHg-like phenotype 
in motor nerve pathfinding. This finding was criticial, as it provides strong evidence for 
an important role of E(spl)mδ in MeHg toxicity; it also implies that the effects of MeHg 
in the system studied are not due to direct toxicity in neurons but instead due to effects on 
the substrate and targets for axon pathfinding. 
 By visualizing the muscles I was able to discern that both MeHg treatment and 
E(spl)mδ overexpression cause gross developmental anomalies in muscle patterning. This 





toxicity in the muscle rather than neurons. Further experiments looking at the co-
occurrence of the nerve and muscle phenotypes implicated factors beyond the gross 
alterations in muscle pattern are impacting the success or failure of neural development. 
Though I attempted to elucidate changes in signaling molecules known to impact motor 
nerve pathfinding I was unable to observe any.  
My experiments were unable to fully elucidate the mechanism by which E(spl)mδ 
overexpression in the muscle was able to cause failure of SN outgrowth. There are 
several possible mechanisms by which this may occur. First, the position of the muscles 
may be compromised; if the muscles are not in the correct position the nerve might not be 
able to find its target and thus stall. This could happen if the muscles are even subtly 
misplaced, such that I could not discern a muscle phenotype but the nerve still failed to 
branch. Failure of the muscles to occupy their proper position could also cause them to 
directly block the normal path of the axon, preventing it from growing normally. The 
other likely explanation for alteration of gene expression in muscles impacting nerve 
development is an alteration in cell-to-cell signaling. This could occur because of a 
failure of the normal attractive cues to be expressed. While I saw no global changes in 
Sidestep expression in Mef2>mδ embryos there might be alteration in the tight 
temporospatial regulation of the signal, which is crucial to the appropriate development 
of the motor nerves (Siebert et al., 2009). More sensitive analysis of Sidestep expression, 
perhaps using sidestep specific antibodies, would be necessary to determine exactly how 
E(spl)mδ overexpression alters sidestep expression. Alternatively, induced expression of 
E(spl)mδ in muscles could also cause inappropriate expression of a repulsive cue. This 





could be assayed simply in a first pass approach using qPCR as I have done here for Side 
and Beat. 
 In this dissertation I also performed experiments to assess E(spl)mδ specificity in 
its ability to induce the changes in muscle and motor nerve phenotype. Using a parallel 
approach I investigated E(spl)mγ activity and found that overexpression in muscle does 
not replicate the phenotypes seen with MeHg or E(spl)mδ. This indicates that E(spl)mδ is 
unique among E(spl)s in its ability to impact muscle development, and contributes to the 
literature showing that E(spl) genes act in discrete tissues during development (Jennings 
et al., 1999). 
 The findings of this work suggest further experiments that would address the 
impact of MeHg on human health. There has already been some study of the effect of 
MeHg on the Notch pathway in rat neural stem cells, but given my findings on the 
important role E(spl)mδ plays in Drosophila it will be worthwhile to more carefully study 
the impact of MeHg on E(spl) homologues, the HES genes, in mammals (Jarriault et al., 
1998; Tamm et al., 2008). My studies show that only one E(spl) gene responds to MeHg 
consistently in the Drosophila embryo. As such it will be important to look at each HES 
gene individually to assess MeHg response. Should one or more HES genes prove to be 
responsive to MeHg experiments that replicate my approach in Drosophila would be 
appropriate; a neural phenotype of MeHg treatment could be identified in a mouse 
embryo and steps taken to attempt to reproduce the phenotype using genetic 
manipulations of HES genes. An additional line of inquiry applicable to human health 
suggested by my results is looking at non-neural contributions to apparently neural 





toxicity in mammals (Castoldi et al., 2001; Aschner et al., 2007; do Nascimento et al., 
2008). My work supports looking deeper into this connection and investigating the role of 
other tissues, such as the circulatory system, that may interact non-autonomously to 
potentiate MeHg neural toxicity. 
 The knowledge gained from my experiments reinforces the link between MeHg 
toxicity and the Notch signaling pathway. Moreover, this work suggests several new 
avenues of study that will continue to refine our understanding of MeHg. With further 
experiments we may be able to make more accurate assessment of the susceptibility or 
tolerance of a developing organism to MeHg, which will eventually inform 
recommendations on seafood intake and lead to ways to ameliorate MeHg toxicity, 
thereby reducing the threat of this global toxin. 
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